data_1wcn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wcn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.307 0.575 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.576 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.52 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 445' ' ' ALA . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.5 m-80 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 440' ' ' VAL . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.576 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.599 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.57 ' CD ' ' CD1' ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.599 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.51 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.582 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.495 ' C ' ' CG1' ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.541 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.471 ' HB3' HD22 ' A' ' 467' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 464' ' ' ILE . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.57 ' CD1' ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.472 ' O ' HD21 ' A' ' 481' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.535 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.512 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.582 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.542 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 445' ' ' ALA . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 73.0 m-80 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.47 ' O ' HD13 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.618 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 440' ' ' VAL . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.482 ' CE ' HG21 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.548 ' CD1' HD11 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.421 ' HG3' HD13 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.525 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.477 ' C ' HG12 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.548 HD11 ' CD1' ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.544 ' CB ' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.502 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.453 ' HA ' ' HB1' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.554 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.482 HG21 ' CE ' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.515 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 477' ' ' LYS . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.577 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.577 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.586 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.545 ' CD2' HD11 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 61.7 m-80 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.52 ' CA ' HD12 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.506 HG12 HD21 ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 435' ' ' LEU . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.506 HD21 HG12 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.574 ' CE ' ' CG2' ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 453' ' ' VAL . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.587 ' NE ' ' CD1' ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.576 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.611 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.522 ' CG2' ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.454 ' C ' HD13 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.587 ' CD1' ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.522 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.522 ' OD1' ' CG2' ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.52 HD12 ' CA ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.506 HG23 ' CZ ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.528 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.611 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 483' ' ' MET . 85.1 m-20 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.351 0.596 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.557 ' HG2' HD22 ' A' ' 435' ' ' LEU . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.541 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 431' ' ' ALA . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 36.5 m-80 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 481' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 441' ' ' ASP . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 453' ' ' VAL . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 445' ' ' ALA . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 446' ' ' PHE . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' HD12 ' A' ' 448' ' ' LEU . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 434' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.504 ' HB2' HG11 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.506 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.435 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.59 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.444 ' HG2' HD22 ' A' ' 481' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.59 ' CG1' ' CD1' ' A' ' 467' ' ' LEU . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 490' ' ' TRP . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.8 m-20 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.498 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.572 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.61 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.504 ' CD2' ' HG3' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.2 m-80 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HG3' ' CD2' ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.61 ' CD1' ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.58 ' O ' HD12 ' A' ' 448' ' ' LEU . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.484 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.539 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.534 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.539 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.558 ' NE2' ' CG2' ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.5 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.525 HD13 ' CG1' ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 467' ' ' LEU . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.5 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.504 ' HG2' ' CD1' ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 474' ' ' THR . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.504 ' CD1' ' HG2' ' A' ' 477' ' ' LYS . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.567 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.539 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.567 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.534 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.462 ' N ' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 430' ' ' PRO . 29.8 tttp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.617 ' CD1' HG13 ' A' ' 440' ' ' VAL . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 62.8 m-80 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.408 ' HA2' HD12 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.617 HG13 ' CD1' ' A' ' 434' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.56 ' HB3' HG12 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 453' ' ' VAL . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.591 ' O ' HD12 ' A' ' 448' ' ' LEU . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 431' ' ' ALA . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 462' ' ' GLN . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.532 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.54 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 462' ' ' GLN . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.515 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.459 ' N ' HG21 ' A' ' 470' ' ' ILE . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 477' ' ' LYS . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.55 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.532 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.426 ' C ' ' HB2' ' A' ' 449' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.358 0.599 . . . . 0.0 109.748 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.56 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.56 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.505 ' CD1' HD23 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.2 m-80 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 440' ' ' VAL . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.56 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.504 ' HG2' HG21 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.567 ' CD2' ' HB ' ' A' ' 453' ' ' VAL . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.567 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 431' ' ' ALA . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.633 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.501 ' C ' HG12 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.549 ' CD2' ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.522 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.526 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.504 HG21 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.529 HD22 ' CB ' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.575 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.633 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.575 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.426 ' SG ' HD22 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.465 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 448' ' ' LEU . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 445' ' ' ALA . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.8 m-80 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.459 ' HD3' HG22 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.568 ' CD2' ' HB ' ' A' ' 453' ' ' VAL . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.453 ' HB3' ' CA ' ' A' ' 430' ' ' PRO . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 446' ' ' PHE . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.484 ' CD ' HD12 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.568 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.612 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.52 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.499 HD12 ' CA ' ' A' ' 479' ' ' GLY . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.522 HG21 ' N ' ' A' ' 471' ' ' GLU . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.522 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 481' ' ' LEU . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.507 ' CD1' ' HA2' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.528 HG23 ' NE ' ' A' ' 486' ' ' ARG . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.612 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 490' ' ' TRP . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.548 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.4 m0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 109.748 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.555 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.4 m-80 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 437' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.43 ' HA ' HD13 ' A' ' 435' ' ' LEU . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.657 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.546 ' CD1' ' HB ' ' A' ' 453' ' ' VAL . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.567 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.443 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.508 ' HB2' HG11 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.581 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.527 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.508 ' CG2' ' HB1' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.563 ' CD2' HD23 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.462 HG21 ' N ' ' A' ' 471' ' ' GLU . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.462 ' N ' HG21 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 478' ' ' ALA . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.445 ' N ' ' CD1' ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 481' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.551 ' CB ' HD13 ' A' ' 473' ' ' LEU . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 477' ' ' LYS . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.549 ' CG1' ' CD2' ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.567 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.648 ' NE ' ' CH2' ' A' ' 490' ' ' TRP . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.443 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.543 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.7 m-80 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.438 ' HA2' ' HG ' ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.615 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 453' ' ' VAL . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.474 ' HA ' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.433 ' NE ' HD13 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.598 ' O ' ' HG ' ' A' ' 448' ' ' LEU . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.634 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.419 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.513 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 453' ' ' VAL . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.546 HD13 ' CG1' ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.534 ' N ' HG21 ' A' ' 470' ' ' ILE . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.468 HD22 ' CB ' ' A' ' 467' ' ' LEU . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.492 ' O ' HD11 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 459' ' ' LEU . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.634 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.56 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.304 0.573 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.545 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.643 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.9 m-80 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.492 ' HA ' HD13 ' A' ' 435' ' ' LEU . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 440' ' ' VAL . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.643 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 446' ' ' PHE . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.601 ' NE ' ' CD1' ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.536 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.637 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.47 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.577 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.526 ' HB2' HD12 ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 462' ' ' GLN . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.601 ' CD1' ' NE ' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.493 ' N ' HG21 ' A' ' 470' ' ' ILE . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.555 HD13 ' CB ' ' A' ' 478' ' ' ALA . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.435 ' N ' HD12 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.555 ' CB ' HD13 ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.441 ' CD2' ' HA2' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.577 ' HA ' ' CD1' ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.637 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.595 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.248 0.547 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.523 HD23 HD21 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 445' ' ' ALA . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.537 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 57.0 m-80 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.461 ' CA ' HD12 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.509 HG12 HD21 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.449 ' HA ' HD22 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.509 HD21 HG12 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 430' ' ' PRO . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.512 ' CE ' HG22 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.535 ' CB ' ' HD3' ' A' ' 430' ' ' PRO . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.529 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.609 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.635 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.456 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.531 ' CB ' HG11 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 448' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 473' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.529 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.513 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.487 ' HD3' ' CD1' ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.668 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.461 HD12 ' CA ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.534 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.635 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.548 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.456 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.499 ' O ' ' CD1' ' A' ' 435' ' ' LEU . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.557 ' HG ' ' CB ' ' A' ' 445' ' ' ALA . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 67.0 m-80 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.454 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 440' ' ' VAL . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.557 ' CB ' ' HG ' ' A' ' 435' ' ' LEU . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.496 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.45 ' HB3' ' CA ' ' A' ' 430' ' ' PRO . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.483 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 431' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.659 ' HG ' ' HB2' ' A' ' 485' ' ' ALA . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.544 HD11 ' CD1' ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.511 HD13 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.496 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.428 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.508 ' HG2' HD11 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.572 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.543 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.659 ' HB2' ' HG ' ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.6 m-20 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.525 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.587 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.575 ' CD2' HD23 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 69.4 m-80 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 444' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 435' ' ' LEU . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.519 ' HB3' HG11 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.601 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.585 ' CD1' ' CD2' ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.458 ' HD3' ' CD1' ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.5 ' C ' HG12 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.585 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.458 ' CD1' ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.48 ' HA ' HG22 ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 483' ' ' MET . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 477' ' ' LYS . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.57 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.534 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.571 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.468 ' HG2' HD13 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.533 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.6 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.559 ' CD2' ' CB ' ' A' ' 445' ' ' ALA . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 72.5 m-80 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.473 ' HA2' HD22 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 441' ' ' ASP . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.536 HD23 ' CG2' ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.559 ' CB ' ' CD2' ' A' ' 435' ' ' LEU . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.439 ' O ' ' HB1' ' A' ' 450' ' ' ALA . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.599 ' CD1' ' O ' ' A' ' 453' ' ' VAL . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.443 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 446' ' ' PHE . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.437 ' HB2' HG22 ' A' ' 453' ' ' VAL . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.589 ' HG ' ' HB2' ' A' ' 485' ' ' ALA . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.529 ' C ' HG12 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.535 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.554 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.501 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 468' ' ' ALA . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 465' ' ' ASP . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 467' ' ' LEU . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.515 HD22 ' CB ' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.459 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.449 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' A' ' 486' ' ' ARG . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.544 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.589 ' HB2' ' HG ' ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.563 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.467 ' O ' HD21 ' A' ' 437' ' ' LEU . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.622 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 64.3 m-80 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 437' ' ' LEU . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.622 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.63 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 448' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.549 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.524 ' HB2' HG11 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.579 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.447 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.476 ' HA ' ' HB1' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.549 HD11 ' CG1' ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.45 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 481' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 464' ' ' ILE . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.549 ' CG1' HD11 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.667 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.549 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.593 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 445' ' ' ALA . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.7 m-80 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.593 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . 0.441 ' HB2' HD11 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . 0.442 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 435' ' ' LEU . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.46 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.487 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.498 ' C ' HG12 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.565 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 475' ' ' ASP . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 471' ' ' GLU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.483 HD12 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.483 ' HD3' HD12 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 477' ' ' LYS . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 459' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.547 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 484' ' ' ALA . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.487 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.538 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.602 ' CD2' HD21 ' A' ' 448' ' ' LEU . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 65.0 m-80 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HB3' HG11 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.6 ' CB ' HD11 ' A' ' 435' ' ' LEU . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.59 ' O ' HD22 ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.501 ' HB2' HG11 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.556 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 471' ' ' GLU . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . 0.534 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 482' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.519 ' CD1' ' HA2' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 467' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.486 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 490' ' ' TRP . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.556 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.536 HD22 ' CB ' ' A' ' 445' ' ' ALA . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 60.8 m-80 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' LEU . . . . . 0.536 ' CD2' HD12 ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 481' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ARG . . . . . 0.53 ' HA ' ' CD2' ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.407 ' C ' HD21 ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.448 ' HG2' HG21 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 453' ' ' VAL . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 445' ' ' ALA . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HD2' HD12 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 448' ' ' LEU . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 431' ' ' ALA . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.469 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLN . . . . . 0.53 ' CG ' HD23 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.41 HG22 ' CB ' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.559 ' CD2' ' CG1' ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.515 HD12 ' HD2' ' A' ' 451' ' ' ARG . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' THR . . . . . 0.432 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.436 ' HB2' HD13 ' A' ' 473' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . 0.443 ' N ' HD21 ' A' ' 481' ' ' LEU . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . 0.559 ' CG1' ' CD2' ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 488' ' ' ILE . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.478 ' HA3' ' HB1' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.34 -40.07 77.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.122 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 429' ' ' LYS . 78.5 m-20 -53.4 -35.48 60.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 66.56 125.72 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.761 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.576 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.52 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.494 HD22 ' CB ' ' A' ' 445' ' ' ALA . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.5 m-80 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 440' ' ' VAL . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.576 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.599 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.478 ' HB1' ' HA3' ' A' ' 426' ' ' GLY . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.57 ' CD ' ' CD1' ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.599 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.51 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.582 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.495 ' C ' ' CG1' ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.541 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.471 ' HB3' HD22 ' A' ' 467' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 464' ' ' ILE . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.57 ' CD1' ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.472 ' O ' HD21 ' A' ' 481' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.535 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.512 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.582 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.405 ' O ' ' HA3' ' A' ' 492' ' ' GLY . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.542 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 -94.01 -85.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.433 ' HB3' ' HB2' ' A' ' 495' ' ' ALA . 85.2 m-85 -47.49 -41.16 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.325 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 79.28 -166.07 51.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -65.1 -29.08 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.89 -34.32 8.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.35 -39.01 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -1.169 . . . . 0.0 109.427 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 450' ' ' ALA . 30.8 m120 57.4 43.28 23.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -90.62 139.95 26.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.52 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.515 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.618 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 445' ' ' ALA . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 73.0 m-80 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.47 ' O ' HD13 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.618 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 440' ' ' VAL . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.515 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.482 ' CE ' HG21 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.548 ' CD1' HD11 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 428' ' ' ASN . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.421 ' HG3' HD13 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.525 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.477 ' C ' HG12 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.548 HD11 ' CD1' ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.544 ' CB ' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.502 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.453 ' HA ' ' HB1' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.554 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.482 HG21 ' CE ' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.515 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 477' ' ' LYS . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.577 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.577 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 492' ' ' GLY . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.455 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.568 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 -102.96 -85.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -46.11 -39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -57.26 100.39 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.58 -32.61 74.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 495' ' ' ALA . 55.7 mp0 -62.08 -31.24 71.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -88.76 5.55 42.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.144 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.441 ' C ' ' HG3' ' A' ' 429' ' ' LYS . 2.9 m120 -106.37 119.85 40.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.393 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -135.89 156.98 76.87 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.134 -0.979 . . . . 0.0 109.467 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.586 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.545 ' CD2' HD11 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 61.7 m-80 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.52 ' CA ' HD12 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.506 HG12 HD21 ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 435' ' ' LEU . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.506 HD21 HG12 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.539 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.574 ' CE ' ' CG2' ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 453' ' ' VAL . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.587 ' NE ' ' CD1' ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.576 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.439 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.611 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.522 ' CG2' ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.454 ' C ' HD13 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.587 ' CD1' ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.522 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.522 ' OD1' ' CG2' ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.52 HD12 ' CA ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.506 HG23 ' CZ ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.528 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.611 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 483' ' ' MET . 85.1 m-20 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 -101.95 -87.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -53.63 -40.66 65.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.665 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 71.59 -124.69 10.94 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.35 -34.87 72.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.425 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 495' ' ' ALA . 97.2 mt-10 -63.03 -33.53 75.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.4 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.465 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.35 -38.12 68.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -1.141 . . . . 0.0 109.577 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.467 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.7 m-20 -74.52 147.51 41.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.423 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt -126.98 147.89 63.42 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.557 ' HG2' HD22 ' A' ' 435' ' ' LEU . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.541 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 431' ' ' ALA . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 36.5 m-80 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 481' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 441' ' ' ASP . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 453' ' ' VAL . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 445' ' ' ALA . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 446' ' ' PHE . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' HD12 ' A' ' 448' ' ' LEU . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 434' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.504 ' HB2' HG11 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.518 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.506 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.435 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.59 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.444 ' HG2' HD22 ' A' ' 481' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.59 ' CG1' ' CD1' ' A' ' 467' ' ' LEU . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 490' ' ' TRP . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.8 m-20 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 495' ' ' ALA . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 -108.67 -93.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -48.3 -44.45 33.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.677 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -55.42 125.36 36.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.9 -37.07 85.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.158 . . . . 0.0 109.203 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.92 -32.95 68.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.508 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.39 43.2 29.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -1.192 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.45 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 92.6 m-20 -100.36 132.21 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -132.02 154.23 81.63 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.498 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.572 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.61 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.504 ' CD2' ' HG3' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.2 m-80 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HG3' ' CD2' ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.61 ' CD1' ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.58 ' O ' HD12 ' A' ' 448' ' ' LEU . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.484 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.539 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.534 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.539 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.558 ' NE2' ' CG2' ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.5 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.525 HD13 ' CG1' ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 467' ' ' LEU . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.5 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.504 ' HG2' ' CD1' ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 474' ' ' THR . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.504 ' CD1' ' HG2' ' A' ' 477' ' ' LYS . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.567 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.539 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.567 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 491' ' ' PHE . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.534 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.462 ' N ' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 -96.7 -83.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 60.5 m-85 -46.06 -38.96 8.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.069 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.42 115.71 4.28 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.79 -40.22 87.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.08 143.52 48.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.531 ' CB ' ' OE2' ' A' ' 457' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 428' ' ' ASN . 27.0 p-10 -62.71 -33.74 75.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -1.177 . . . . 0.0 109.456 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 427' ' ' ASP . 80.4 m-20 -113.69 135.81 53.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.533 ' CG ' ' HD2' ' A' ' 430' ' ' PRO . 29.8 tttp -141.74 140.73 20.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.535 ' CB ' ' HB3' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.617 ' CD1' HG13 ' A' ' 440' ' ' VAL . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 62.8 m-80 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.408 ' HA2' HD12 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.617 HG13 ' CD1' ' A' ' 434' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.56 ' HB3' HG12 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.497 ' HE2' HG22 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 453' ' ' VAL . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.591 ' O ' HD12 ' A' ' 448' ' ' LEU . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 431' ' ' ALA . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 462' ' ' GLN . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.532 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.54 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 462' ' ' GLN . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.515 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.459 ' N ' HG21 ' A' ' 470' ' ' ILE . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 477' ' ' LYS . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.55 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.532 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 -101.69 -83.05 0.46 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -52.7 -38.61 60.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -84.33 -171.18 47.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 57.6 p30 -135.64 176.23 8.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -1.107 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -101.57 151.23 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.501 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.446 ' HA3' ' HB1' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -57.01 -40.71 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.477 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 83.4 m-20 -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.92 . . . . 0.0 109.33 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 73.03 131.4 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.56 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.56 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.505 ' CD1' HD23 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.2 m-80 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.469 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.488 ' HA ' ' CD1' ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 440' ' ' VAL . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.56 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.504 ' HG2' HG21 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.567 ' CD2' ' HB ' ' A' ' 453' ' ' VAL . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.567 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 431' ' ' ALA . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.633 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.501 ' C ' HG12 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.549 ' CD2' ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.522 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.526 ' CD1' ' CG1' ' A' ' 482' ' ' ILE . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.504 HG21 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.529 HD22 ' CB ' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.445 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.575 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.633 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.575 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.426 ' SG ' HD22 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.465 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 -99.75 -85.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -57.7 -43.1 84.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.377 -0.827 . . . . 0.0 109.694 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -87.54 -179.97 47.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -98.95 163.96 12.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -1.144 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.437 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.53 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -55.05 -38.72 68.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -1.131 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 449' ' ' ALA . 88.4 m-20 -105.12 127.16 52.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER -122.39 135.82 25.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.554 ' CD1' HD23 ' A' ' 448' ' ' LEU . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 445' ' ' ALA . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.8 m-80 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.459 ' HD3' HG22 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.568 ' CD2' ' HB ' ' A' ' 453' ' ' VAL . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 428' ' ' ASN . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 428' ' ' ASN . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.484 ' CD ' HD12 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.568 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.612 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.544 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.52 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.499 HD12 ' CA ' ' A' ' 479' ' ' GLY . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.527 HD11 ' CG1' ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.522 HG21 ' N ' ' A' ' 471' ' ' GLU . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.522 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 481' ' ' LEU . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.507 ' CD1' ' HA2' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.528 HG23 ' NE ' ' A' ' 486' ' ' ARG . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.612 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 490' ' ' TRP . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 491' ' ' PHE . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.548 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.4 m0 -112.32 -80.73 0.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.548 ' CB ' ' O ' ' A' ' 490' ' ' TRP . 21.1 t80 80.29 -54.53 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 109.353 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.05 47.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.42 -36.41 63.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -1.171 . . . . 0.0 109.403 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.86 145.14 45.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.478 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -86.91 6.43 32.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.534 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.489 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 91.6 m-20 -107.98 133.87 51.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.305 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -121.49 145.88 43.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.555 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.4 m-80 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 437' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.43 ' HA ' HD13 ' A' ' 435' ' ' LEU . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.657 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.546 ' CD1' ' HB ' ' A' ' 453' ' ' VAL . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.567 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.443 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.508 ' HB2' HG11 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.581 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.527 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.508 ' CG2' ' HB1' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.563 ' CD2' HD23 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.462 HG21 ' N ' ' A' ' 471' ' ' GLU . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.462 ' N ' HG21 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 478' ' ' ALA . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.445 ' N ' ' CD1' ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 481' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.551 ' CB ' HD13 ' A' ' 473' ' ' LEU . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 477' ' ' LYS . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.549 ' CG1' ' CD2' ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.567 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.648 ' NE ' ' CH2' ' A' ' 490' ' ' TRP . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.443 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 -95.22 -84.94 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 490' ' ' TRP . 24.7 m-85 -43.45 -38.24 2.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -55.27 -31.49 56.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 490' ' ' TRP . 91.6 m-20 -59.25 -34.91 72.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.144 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -34.07 71.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.477 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 58.27 39.77 25.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -1.12 . . . . 0.0 109.564 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 449' ' ' ALA . 50.8 m-20 -87.41 142.68 27.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -98.03 139.69 21.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.543 ' HG3' ' CB ' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.7 m-80 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.438 ' HA2' ' HG ' ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.565 HD23 ' CG2' ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.615 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 453' ' ' VAL . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.474 ' HA ' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.433 ' NE ' HD13 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.598 ' O ' ' HG ' ' A' ' 448' ' ' LEU . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.634 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.419 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.513 ' O ' ' NE ' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.51 ' NE2' HG23 ' A' ' 453' ' ' VAL . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.546 HD13 ' CG1' ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.534 ' N ' HG21 ' A' ' 470' ' ' ILE . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.468 HD22 ' CB ' ' A' ' 467' ' ' LEU . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.492 ' O ' HD11 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 459' ' ' LEU . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.634 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.56 ' NE ' ' CG2' ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 -97.74 -85.25 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.41 -39.63 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 74.69 26.98 66.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.59 134.94 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -1.19 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.1 -34.76 79.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.476 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -55.18 -38.03 67.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 449' ' ' ALA . 84.1 m-20 57.78 54.17 6.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.04 151.0 87.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.545 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 456' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.643 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.9 m-80 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.492 ' HA ' HD13 ' A' ' 435' ' ' LEU . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 440' ' ' VAL . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.643 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 450' ' ' ALA . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 428' ' ' ASN . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 446' ' ' PHE . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.601 ' NE ' ' CD1' ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.536 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.637 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.47 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.577 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.526 ' HB2' HD12 ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 462' ' ' GLN . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.601 ' CD1' ' NE ' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.493 ' N ' HG21 ' A' ' 470' ' ' ILE . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.555 HD13 ' CB ' ' A' ' 478' ' ' ALA . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.435 ' N ' HD12 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.555 ' CB ' HD13 ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.441 ' CD2' ' HA2' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.577 ' HA ' ' CD1' ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.637 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.595 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 -92.7 -85.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -48.85 -39.5 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.285 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.55 143.33 30.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.9 138.52 54.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 495' ' ' ALA . 73.3 mm-40 -63.48 -33.35 75.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . 0.413 ' O ' ' SG ' ' A' ' 454' ' ' CYS . 93.1 m-20 -55.96 -37.17 68.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -1.181 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.548 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 24.6 m120 -54.25 -36.97 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp -48.22 136.88 11.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.523 HD23 HD21 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 445' ' ' ALA . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.537 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 57.0 m-80 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.461 ' CA ' HD12 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.509 HG12 HD21 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.449 ' HA ' HD22 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.509 HD21 HG12 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 430' ' ' PRO . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.512 ' CE ' HG22 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.535 ' CB ' ' HD3' ' A' ' 430' ' ' PRO . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.529 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.609 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.559 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.635 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.456 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.531 ' CB ' HG11 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 448' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.548 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 473' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.529 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.513 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.487 ' HD3' ' CD1' ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.668 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.461 HD12 ' CA ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.534 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.635 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.548 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 492' ' ' GLY . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.456 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 -103.11 -90.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -49.94 -43.53 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -45.24 102.73 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -91.75 114.83 27.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -1.098 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.18 152.97 23.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.682 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.485 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 55.6 45.24 25.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 449' ' ' ALA . 0.9 OUTLIER 57.49 39.38 27.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.49 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -82.44 150.31 63.26 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.499 ' O ' ' CD1' ' A' ' 435' ' ' LEU . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.5 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.557 ' HG ' ' CB ' ' A' ' 445' ' ' ALA . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 67.0 m-80 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.454 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 440' ' ' VAL . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.557 ' CB ' ' HG ' ' A' ' 435' ' ' LEU . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.496 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 453' ' ' VAL . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 428' ' ' ASN . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.483 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 431' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.659 ' HG ' ' HB2' ' A' ' 485' ' ' ALA . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.607 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.544 HD11 ' CD1' ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.59 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.511 HD13 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.496 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.428 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.508 ' HG2' HD11 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.572 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.543 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.659 ' HB2' ' HG ' ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.6 m-20 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 492' ' ' GLY . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 -96.17 -83.22 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 492' ' ' GLY . 57.3 m-85 -47.27 -36.19 8.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.869 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 491' ' ' PHE . . . -49.87 -176.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.31 6.65 25.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -1.127 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 489' ' ' CYS . 77.4 tt0 -51.82 -33.68 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.31 -35.76 72.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -1.11 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -108.71 128.94 55.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -134.89 153.56 78.74 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.525 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.587 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.575 ' CD2' HD23 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 69.4 m-80 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 444' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 435' ' ' LEU . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.519 ' HB3' HG11 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.601 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.585 ' CD1' ' CD2' ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.458 ' HD3' ' CD1' ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.5 ' C ' HG12 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.585 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.458 ' CD1' ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.48 ' HA ' HG22 ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.483 ' HG2' HD11 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 483' ' ' MET . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 477' ' ' LYS . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.57 ' CG2' ' NE ' ' A' ' 486' ' ' ARG . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.534 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.571 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 485' ' ' ALA . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 -94.99 -83.88 0.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -55.42 -39.07 69.79 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.349 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -79.7 142.9 25.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.66 115.59 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -1.146 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -56.17 142.59 36.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.447 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -58.28 -34.66 70.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 0.0 109.504 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.19 131.35 42.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -137.77 148.54 61.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.482 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.468 ' HG2' HD13 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.533 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.6 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.559 ' CD2' ' CB ' ' A' ' 445' ' ' ALA . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 72.5 m-80 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.473 ' HA2' HD22 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 441' ' ' ASP . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.536 HD23 ' CG2' ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.559 ' CB ' ' CD2' ' A' ' 435' ' ' LEU . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.439 ' O ' ' HB1' ' A' ' 450' ' ' ALA . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.599 ' CD1' ' O ' ' A' ' 453' ' ' VAL . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.443 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 446' ' ' PHE . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.437 ' HB2' HG22 ' A' ' 453' ' ' VAL . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.589 ' HG ' ' HB2' ' A' ' 485' ' ' ALA . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.529 ' C ' HG12 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.535 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.554 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.501 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 468' ' ' ALA . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 465' ' ' ASP . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 467' ' ' LEU . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.515 HD22 ' CB ' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.459 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.449 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' A' ' 486' ' ' ARG . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.544 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.589 ' HB2' ' HG ' ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 492' ' ' GLY . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.516 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -93.6 -81.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 62.5 m-85 -56.69 -37.74 71.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.791 . . . . 0.0 109.264 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.97 -178.8 44.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 52.7 p30 -150.74 176.3 11.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -1.157 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -105.17 152.28 23.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.442 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.488 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -57.13 -36.43 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -1.096 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.438 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 87.6 m-20 -105.63 137.97 42.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp -122.93 146.1 47.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.563 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.467 ' O ' HD21 ' A' ' 437' ' ' LEU . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.622 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 64.3 m-80 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 437' ' ' LEU . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.622 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.63 ' CB ' ' CD1' ' A' ' 435' ' ' LEU . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 448' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.549 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.458 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.524 ' HB2' HG11 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.579 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.447 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.476 ' HA ' ' HB1' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.549 HD11 ' CG1' ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.45 ' O ' HD22 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.443 ' O ' HD12 ' A' ' 481' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 464' ' ' ILE . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.549 ' CG1' HD11 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.667 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.549 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 -93.24 -84.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -50.74 -39.9 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 56.7 -134.38 51.67 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 48.16 36.32 6.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.184 -1.186 . . . . 0.0 109.38 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 495' ' ' ALA . 84.3 tt0 -62.63 -34.23 76.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.05 -36.76 70.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -107.24 135.09 49.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.37 141.8 31.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.595 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.593 ' CD1' ' CG1' ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 445' ' ' ALA . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.7 m-80 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.403 ' O ' HD13 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.593 ' CG1' ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . 0.441 ' HB2' HD11 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . 0.442 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 435' ' ' LEU . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 450' ' ' ALA . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 446' ' ' PHE . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.46 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 485' ' ' ALA . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.487 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.498 ' C ' HG12 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.562 ' CD1' ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.565 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.463 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 475' ' ' ASP . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 467' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 471' ' ' GLU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.483 HD12 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.49 ' HA ' HG22 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.483 ' HD3' HD12 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 474' ' ' THR . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 477' ' ' LYS . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 459' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.547 ' CB ' ' HG ' ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 484' ' ' ALA . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.487 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 -93.89 -84.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 14.8 m-85 -43.78 -41.97 5.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -80.2 132.13 11.08 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -96.46 6.61 48.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -1.147 . . . . 0.0 109.553 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.38 -33.2 74.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.474 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -57.14 -34.22 68.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -1.168 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.468 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.9 m-20 -93.34 143.66 26.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER -109.93 149.91 40.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.308 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.538 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.602 ' CD2' HD21 ' A' ' 448' ' ' LEU . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 65.0 m-80 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HB3' HG11 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.6 ' CB ' HD11 ' A' ' 435' ' ' LEU . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.59 ' O ' HD22 ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.501 ' HB2' HG11 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.556 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 471' ' ' GLU . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . 0.534 ' N ' HG21 ' A' ' 470' ' ' ILE . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . . . . . . . . . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 482' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.519 ' CD1' ' HA2' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 467' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.486 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 490' ' ' TRP . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 492' ' ' GLY . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -97.91 -83.43 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -53.1 -38.79 62.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.473 -0.767 . . . . 0.0 109.274 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -58.78 123.76 34.45 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 494' ' ' GLU . 28.3 p-10 -67.55 -33.16 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -1.126 . . . . 0.0 109.293 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 493' ' ' ASP . 97.5 mt-10 -62.84 -32.88 74.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.83 -25.72 68.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -1.189 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 449' ' ' ALA . 20.6 m120 -92.21 13.17 19.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm -64.67 150.64 93.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.556 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.536 HD22 ' CB ' ' A' ' 445' ' ' ALA . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 60.8 m-80 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.536 ' CD2' HD12 ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 481' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.53 ' HA ' ' CD2' ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.407 ' C ' HD21 ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.448 ' HG2' HG21 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 453' ' ' VAL . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 428' ' ' ASN . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.515 ' HD2' HD12 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 448' ' ' LEU . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 431' ' ' ALA . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 482' ' ' ILE . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.469 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLN . . . . . 0.53 ' CG ' HD23 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.41 HG22 ' CB ' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.559 ' CD2' ' CG1' ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.515 HD12 ' HD2' ' A' ' 451' ' ' ARG . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' THR . . . . . 0.432 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.436 ' HB2' HD13 ' A' ' 473' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . 0.443 ' N ' HD21 ' A' ' 481' ' ' LEU . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.559 ' CG1' ' CD2' ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 488' ' ' ILE . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 -102.78 -83.93 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -46.25 -38.06 8.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -46.12 -42.35 12.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.28 -34.27 74.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -1.144 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -76.21 141.2 41.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.469 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.307 0.575 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.751 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.137 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 430' ' ' PRO . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 456' ' ' LEU . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.757 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.137 HG11 ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 444' ' ' LEU . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.751 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.773 ' CD1' HD13 ' A' ' 459' ' ' LEU . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.739 ' CD ' HD11 ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.869 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.576 ' HB2' HG12 ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.773 HD13 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.774 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 478' ' ' ALA . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.739 HD11 ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.581 HD12 ' HD3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 473' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.76 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.779 ' CD1' HG23 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.796 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.869 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.796 ' NE ' HG22 ' A' ' 482' ' ' ILE . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.848 ' SG ' HD23 ' A' ' 456' ' ' LEU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.145 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 430' ' ' PRO . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.757 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.145 HG11 ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 444' ' ' LEU . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 1.065 HD11 HD13 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.78 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.493 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.065 HD13 HD11 ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.509 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.868 HG23 ' CB ' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.627 ' CD1' HD11 ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.868 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.757 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.627 HD11 ' CD1' ' A' ' 467' ' ' LEU . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.78 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.699 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.574 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.923 HD22 HD12 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 31.5 m120 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 456' ' ' LEU . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.819 ' HB3' HG13 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.694 ' HE3' HG22 ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.923 HD12 HD22 ' A' ' 434' ' ' LEU . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.783 HD11 ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.667 HG21 ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.83 HD12 ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.454 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.534 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 474' ' ' THR . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.628 ' CA ' HD11 ' A' ' 464' ' ' ILE . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.596 HG22 ' NE ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.783 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.351 0.596 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.673 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.74 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.713 HD13 HD12 ' A' ' 448' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 430' ' ' PRO . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 1.064 HD22 ' CD1' ' A' ' 456' ' ' LEU . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.863 HG13 HD22 ' A' ' 444' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.863 HD22 HG13 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 434' ' ' LEU . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.644 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.74 HG22 ' HB2' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 1.064 ' CD1' HD22 ' A' ' 437' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.644 ' C ' HG13 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.524 ' NE2' HG22 ' A' ' 453' ' ' VAL . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.63 HD11 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.566 HD23 ' HD3' ' A' ' 477' ' ' LYS . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 473' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.66 ' CD1' HG23 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 486' ' ' ARG . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.798 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.806 ' HD2' HG22 ' A' ' 482' ' ' ILE . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.464 ' CG ' ' O ' ' A' ' 483' ' ' MET . 15.6 m120 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.58 HD12 ' CD1' ' A' ' 437' ' ' LEU . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.47 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.972 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.863 ' CD2' HD12 ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.895 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 30.7 m120 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 456' ' ' LEU . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.73 ' O ' HD21 ' A' ' 481' ' ' LEU . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.84 HG13 HD22 ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.895 ' HA ' HD23 ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.972 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.863 HD12 ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.682 HG22 ' NE2' ' A' ' 462' ' ' GLN . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 437' ' ' LEU . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.534 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.615 ' C ' HG13 ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 459' ' ' LEU . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.682 ' NE2' HG22 ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 470' ' ' ILE . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.443 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 439' ' ' GLY . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.654 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.895 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.654 ' NE ' HG22 ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 437' ' ' LEU . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 456' ' ' LEU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.424 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.704 ' N ' ' HG ' ' A' ' 454' ' ' CYS . 29.8 tttp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.607 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 456' ' ' LEU . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 434' ' ' LEU . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 1.007 HD22 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.861 HG13 HD22 ' A' ' 444' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.861 HD22 HG13 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.678 ' HE2' HG23 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' A' ' 434' ' ' LEU . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.737 ' CD ' HD11 ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.704 ' HG ' ' N ' ' A' ' 429' ' ' LYS . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 1.007 ' CD1' HD22 ' A' ' 437' ' ' LEU . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.603 ' C ' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.775 HD11 HD21 ' A' ' 467' ' ' LEU . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.669 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.544 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.898 HG23 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.777 HD13 HD11 ' A' ' 482' ' ' ILE . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.943 ' HB ' HD12 ' A' ' 473' ' ' LEU . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.943 HD12 ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.451 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.898 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.777 HD11 HD13 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.845 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.669 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.358 0.599 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.866 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.667 ' CD2' HD22 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 29.6 m120 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.7 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.597 HG13 HD22 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HA ' HD11 ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 444' ' ' LEU . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.866 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 434' ' ' LEU . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.868 HD11 ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.545 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.005 HD21 ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.604 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.474 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 478' ' ' ALA . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 473' ' ' LEU . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 1.047 ' CD2' ' HB2' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' A' ' 481' ' ' LEU . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 1.047 ' HB2' ' CD2' ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 1.005 ' HA ' HD21 ' A' ' 459' ' ' LEU . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.868 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.604 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.726 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 440' ' ' VAL . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 1.039 HD23 HG23 ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.863 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 444' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.727 ' HA ' HD23 ' A' ' 435' ' ' LEU . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.559 ' HD3' HG23 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.759 HD22 HD21 ' A' ' 434' ' ' LEU . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 430' ' ' PRO . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.505 ' HD2' HD11 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 431' ' ' ALA . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.762 ' O ' HD23 ' A' ' 459' ' ' LEU . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.559 HG23 ' HD3' ' A' ' 447' ' ' LYS . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 477' ' ' LYS . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' HD3' HD23 ' A' ' 473' ' ' LEU . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.836 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.863 HD13 ' HA3' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.617 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.645 ' NE ' HG22 ' A' ' 482' ' ' ILE . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.4 m0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 109.748 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.783 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.684 HD13 ' CD1' ' A' ' 448' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 29.8 m120 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 444' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.783 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 434' ' ' LEU . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.789 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.567 ' C ' HG13 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 467' ' ' LEU . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.692 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.931 HG23 ' CB ' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.434 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.87 HD22 ' HD3' ' A' ' 477' ' ' LYS . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.831 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.87 ' HD3' HD22 ' A' ' 473' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.931 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 439' ' ' GLY . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.954 HD11 HD22 ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.789 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.692 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.613 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.843 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.985 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.499 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.985 HG11 ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.833 HD22 HG22 ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.908 HD23 ' HG ' ' A' ' 434' ' ' LEU . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.709 HG13 ' C ' ' A' ' 458' ' ' ASP . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.442 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.709 ' C ' HG13 ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.668 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 478' ' ' ALA . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.744 HG22 ' NE ' ' A' ' 486' ' ' ARG . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.792 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.744 ' NE ' HG22 ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 457' ' ' GLU . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.304 0.573 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.767 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.812 HD13 HD23 ' A' ' 448' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 444' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 444' ' ' LEU . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.767 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.548 ' HD3' HG23 ' A' ' 470' ' ' ILE . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.924 HD11 HD23 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.625 ' HD2' HD11 ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 458' ' ' ASP . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.833 HD11 ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.476 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.559 ' C ' HG13 ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.924 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.636 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 478' ' ' ALA . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 459' ' ' LEU . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.766 HD13 ' N ' ' A' ' 474' ' ' THR . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.725 ' HD3' HD22 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.727 ' HA ' HD11 ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.666 ' HD2' HG22 ' A' ' 482' ' ' ILE . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.248 0.547 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.78 ' CD2' HD22 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 442' ' ' ARG . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.733 HG13 HD22 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.784 ' HA ' HD23 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.733 HD22 HG13 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.569 ' HA ' HD23 ' A' ' 434' ' ' LEU . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.673 ' CE ' HG23 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 1.002 HD11 HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.529 ' CB ' ' HD3' ' A' ' 430' ' ' PRO . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.771 ' CD ' HD11 ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.822 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.482 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.641 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.034 HD11 HD21 ' A' ' 467' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 1.034 HD21 HD11 ' A' ' 459' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 464' ' ' ILE . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.771 HD11 ' CD ' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.424 ' H ' ' HE2' ' A' ' 447' ' ' LYS . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.598 HD12 ' HD3' ' A' ' 477' ' ' LYS . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.598 ' HD3' HD12 ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 1.016 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.64 ' CG1' HD22 ' A' ' 467' ' ' LEU . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.559 ' NE ' HG22 ' A' ' 482' ' ' ILE . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.613 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.121 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 430' ' ' PRO . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.524 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.121 HG11 ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.853 ' O ' HD23 ' A' ' 444' ' ' LEU . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.613 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.492 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 1.018 HD11 HD13 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.658 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.93 ' HD2' HD11 ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.658 ' SG ' ' HB1' ' A' ' 449' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.673 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 437' ' ' LEU . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.644 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.018 HD13 HD11 ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.697 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.561 ' CD1' HD11 ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.93 HD11 ' HD2' ' A' ' 451' ' ' ARG . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.536 HD21 HD22 ' A' ' 481' ' ' LEU . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HG2' HD13 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.559 HD13 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.814 HG22 ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.814 ' NE ' HG22 ' A' ' 482' ' ' ILE . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.791 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.843 HD22 HD22 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 34.6 m120 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.653 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.756 HG11 ' CD2' ' A' ' 434' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.791 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.807 ' HD3' HD11 ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.755 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.885 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.686 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 482' ' ' ILE . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.807 HD11 ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.469 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 473' ' ' LEU . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.439 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.591 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 467' ' ' LEU . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.885 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.776 ' NE ' HG22 ' A' ' 482' ' ' ILE . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.883 ' SG ' HD23 ' A' ' 456' ' ' LEU . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.819 ' HG2' HD11 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.066 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 430' ' ' PRO . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.731 ' C ' HD21 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.066 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.89 HD22 HG22 ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 470' ' ' ILE . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.818 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 448' ' ' LEU . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.77 HD23 ' SG ' ' A' ' 489' ' ' CYS . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.436 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.557 ' HB3' HG13 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 467' ' ' LEU . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.507 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 459' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 447' ' ' LYS . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.975 HD21 ' HB2' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.975 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.81 HD22 HG23 ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 467' ' ' LEU . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.77 ' SG ' HD23 ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.636 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.048 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 33.8 m120 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.798 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.048 HG11 ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.775 HD22 HG22 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.78 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.988 ' HD2' HD11 ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 458' ' ' ASP . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.816 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.468 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.585 ' HB3' HG13 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 467' ' ' LEU . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.996 HG23 ' HB3' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.988 HD11 ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 473' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 1.039 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.673 HD11 HD12 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.816 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.781 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 1.024 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 430' ' ' PRO . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 456' ' ' LEU . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.024 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ASP . . . . . 0.477 ' HB2' HD13 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ASP . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.781 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 470' ' ' ILE . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.471 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.83 HD23 ' SG ' ' A' ' 489' ' ' CYS . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.487 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.541 ' C ' HG13 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.888 HG23 ' CB ' ' A' ' 478' ' ' ALA . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 459' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.608 ' CG2' HD23 ' A' ' 473' ' ' LEU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 473' ' ' LEU . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.706 HD13 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.706 ' HD3' HD13 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.888 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.784 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 467' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.779 ' HA ' HD21 ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.83 ' SG ' HD23 ' A' ' 456' ' ' LEU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.739 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.848 ' CD2' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 33.9 m120 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 1.08 HD23 HG23 ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.751 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 1.08 HG23 HD23 ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.828 ' HD3' HG23 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 470' ' ' ILE . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.598 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . 0.534 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.803 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 459' ' ' LEU . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 478' ' ' ALA . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.828 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 473' ' ' LEU . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.751 HD13 ' HA3' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.745 HG12 HD21 ' A' ' 459' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.63 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.803 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.733 ' HD2' HG22 ' A' ' 482' ' ' ILE . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.69 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 432' ' ' ASP . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 442' ' ' ARG . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 32.4 m120 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.563 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.773 HG11 ' HG ' ' A' ' 434' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ARG . . . . . 0.767 ' HA ' HD23 ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.69 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.674 ' HG2' HG23 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.87 HD12 HD23 ' A' ' 434' ' ' LEU . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.62 ' HD2' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.668 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.796 HD11 ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ASP . . . . . 0.668 ' C ' HG13 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 467' ' ' LEU . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLN . . . . . 0.575 ' CG ' HD22 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.674 HG23 ' HG2' ' A' ' 447' ' ' LYS . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 481' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.796 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.585 HD12 HG23 ' A' ' 440' ' ' VAL . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 483' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ALA . . . . . 0.796 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.768 ' HD2' HG22 ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 484' ' ' ALA . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' CYS . . . . . 0.698 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.34 -40.07 77.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.122 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.497 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 78.5 m-20 -53.4 -35.48 60.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 66.56 125.72 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.761 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.751 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.137 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 430' ' ' PRO . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 456' ' ' LEU . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.757 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.137 HG11 ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.718 ' O ' HD23 ' A' ' 444' ' ' LEU . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.751 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.773 ' CD1' HD13 ' A' ' 459' ' ' LEU . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.584 ' HB2' ' HA2' ' A' ' 426' ' ' GLY . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.739 ' CD ' HD11 ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.869 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.576 ' HB2' HG12 ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.773 HD13 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.774 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 478' ' ' ALA . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.739 HD11 ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.581 HD12 ' HD3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 473' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.76 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.779 ' CD1' HG23 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.796 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.869 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.796 ' NE ' HG22 ' A' ' 482' ' ' ILE . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 492' ' ' GLY . 23.4 m120 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.412 ' O ' ' HA2' ' A' ' 492' ' ' GLY . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.848 ' SG ' HD23 ' A' ' 456' ' ' LEU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 -94.01 -85.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.899 ' HB3' ' HB3' ' A' ' 495' ' ' ALA . 85.2 m-85 -47.49 -41.16 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.325 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 79.28 -166.07 51.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -65.1 -29.08 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.89 -34.32 8.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.35 -39.01 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -1.169 . . . . 0.0 109.427 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 450' ' ' ALA . 30.8 m120 57.4 43.28 23.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -90.62 139.95 26.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.52 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.145 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 430' ' ' PRO . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.757 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.145 HG11 ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 444' ' ' LEU . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 1.065 HD11 HD13 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 428' ' ' ASN . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.78 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.493 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.065 HD13 HD11 ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.509 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.868 HG23 ' CB ' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.627 ' CD1' HD11 ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.868 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.757 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.627 HD11 ' CD1' ' A' ' 467' ' ' LEU . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.78 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.699 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 492' ' ' GLY . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.624 ' O ' ' HB2' ' A' ' 495' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.574 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 -102.96 -85.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -46.11 -39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -57.26 100.39 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.58 -32.61 74.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 495' ' ' ALA . 55.7 mp0 -62.08 -31.24 71.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ASP . . . . . 0.4 ' OD1' ' ND2' ' A' ' 428' ' ' ASN . 56.6 p30 -88.76 5.55 42.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.144 . . . . 0.0 109.571 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.43 ' C ' ' HG3' ' A' ' 429' ' ' LYS . 1.8 m-80 -106.37 119.85 40.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.393 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -135.89 156.98 76.87 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.134 -0.979 . . . . 0.0 109.467 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.923 HD22 HD12 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 31.5 m120 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 456' ' ' LEU . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.819 ' HB3' HG13 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.694 ' HE3' HG22 ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.923 HD12 HD22 ' A' ' 434' ' ' LEU . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.783 HD11 ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.667 HG21 ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.83 HD12 ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.454 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.534 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 474' ' ' THR . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.628 ' CA ' HD11 ' A' ' 464' ' ' ILE . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.596 HG22 ' NE ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.783 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 492' ' ' GLY . 27.6 m120 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 -101.95 -87.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -53.63 -40.66 65.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.665 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 71.59 -124.69 10.94 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.35 -34.87 72.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.425 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 97.2 mt-10 -63.03 -33.53 75.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.4 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.465 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.35 -38.12 68.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -1.141 . . . . 0.0 109.577 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.476 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.7 m-20 -74.52 147.51 41.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.423 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt -126.98 147.89 63.42 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.673 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.74 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.713 HD13 HD12 ' A' ' 448' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 430' ' ' PRO . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 1.064 HD22 ' CD1' ' A' ' 456' ' ' LEU . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.863 HG13 HD22 ' A' ' 444' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.863 HD22 HG13 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 434' ' ' LEU . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.644 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.74 HG22 ' HB2' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 1.064 ' CD1' HD22 ' A' ' 437' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.644 ' C ' HG13 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.524 ' NE2' HG22 ' A' ' 453' ' ' VAL . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.63 HD11 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.566 HD23 ' HD3' ' A' ' 477' ' ' LYS . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 473' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.66 ' CD1' HG23 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 486' ' ' ARG . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.798 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.806 ' HD2' HG22 ' A' ' 482' ' ' ILE . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 492' ' ' GLY . 15.6 m120 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.58 HD12 ' CD1' ' A' ' 437' ' ' LEU . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 495' ' ' ALA . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.47 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 -108.67 -93.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -48.3 -44.45 33.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.677 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -55.42 125.36 36.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.9 -37.07 85.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.158 . . . . 0.0 109.203 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 84.3 tt0 -57.92 -32.95 68.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.508 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.39 43.2 29.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -1.192 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 92.6 m-20 -100.36 132.21 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -132.02 154.23 81.63 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.972 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.863 ' CD2' HD12 ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.895 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 30.7 m120 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 456' ' ' LEU . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.73 ' O ' HD21 ' A' ' 481' ' ' LEU . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.84 HG13 HD22 ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.895 ' HA ' HD23 ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.972 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.863 HD12 ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.682 HG22 ' NE2' ' A' ' 462' ' ' GLN . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 437' ' ' LEU . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.708 ' OE2' ' HB1' ' A' ' 495' ' ' ALA . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.615 ' C ' HG13 ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 459' ' ' LEU . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.682 ' NE2' HG22 ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 470' ' ' ILE . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.443 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 439' ' ' GLY . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.654 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.895 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.654 ' NE ' HG22 ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 491' ' ' PHE . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 437' ' ' LEU . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 456' ' ' LEU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.424 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 -96.7 -83.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 60.5 m-85 -46.06 -38.96 8.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.069 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -86.42 115.71 4.28 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.79 -40.22 87.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.08 143.52 48.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.708 ' HB1' ' OE2' ' A' ' 457' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 428' ' ' ASN . 27.0 p-10 -62.71 -33.74 75.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -1.177 . . . . 0.0 109.456 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 427' ' ' ASP . 80.4 m-20 -113.69 135.81 53.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 430' ' ' PRO . 29.8 tttp -141.74 140.73 20.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.607 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 456' ' ' LEU . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 434' ' ' LEU . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 1.007 HD22 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.861 HG13 HD22 ' A' ' 444' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.861 HD22 HG13 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.678 ' HE2' HG23 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' A' ' 434' ' ' LEU . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.737 ' CD ' HD11 ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 431' ' ' ALA . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 1.007 ' CD1' HD22 ' A' ' 437' ' ' LEU . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.603 ' C ' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.775 HD11 HD21 ' A' ' 467' ' ' LEU . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.669 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.544 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.898 HG23 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.777 HD13 HD11 ' A' ' 482' ' ' ILE . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.943 ' HB ' HD12 ' A' ' 473' ' ' LEU . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.943 HD12 ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.451 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.898 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.777 HD11 HD13 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.845 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.669 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 -101.69 -83.05 0.46 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -52.7 -38.61 60.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -84.33 -171.18 47.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 57.6 p30 -135.64 176.23 8.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -1.107 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -101.57 151.23 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.501 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.643 ' HA2' ' HB2' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -57.01 -40.71 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.493 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 83.4 m-20 -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.92 . . . . 0.0 109.33 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 73.03 131.4 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.866 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.667 ' CD2' HD22 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 29.6 m120 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.7 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.597 HG13 HD22 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HA ' HD11 ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.676 ' O ' HD23 ' A' ' 444' ' ' LEU . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.866 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 434' ' ' LEU . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.643 ' HB2' ' HA2' ' A' ' 426' ' ' GLY . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.868 HD11 ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.545 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.005 HD21 ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.604 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.474 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 478' ' ' ALA . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 473' ' ' LEU . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 1.047 ' CD2' ' HB2' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' A' ' 481' ' ' LEU . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 1.047 ' HB2' ' CD2' ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 1.005 ' HA ' HD21 ' A' ' 459' ' ' LEU . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.868 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.604 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 -99.75 -85.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -57.7 -43.1 84.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.377 -0.827 . . . . 0.0 109.694 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -87.54 -179.97 47.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -98.95 163.96 12.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -1.144 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.437 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.53 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -55.05 -38.72 68.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -1.131 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 449' ' ' ALA . 88.4 m-20 -105.12 127.16 52.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER -122.39 135.82 25.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.726 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 440' ' ' VAL . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 1.039 HD23 HG23 ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.863 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 444' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.727 ' HA ' HD23 ' A' ' 435' ' ' LEU . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.559 ' HD3' HG23 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.759 HD22 HD21 ' A' ' 434' ' ' LEU . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 428' ' ' ASN . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 428' ' ' ASN . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.505 ' HD2' HD11 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 431' ' ' ALA . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.762 ' O ' HD23 ' A' ' 459' ' ' LEU . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.559 HG23 ' HD3' ' A' ' 447' ' ' LYS . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 477' ' ' LYS . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' HD3' HD23 ' A' ' 473' ' ' LEU . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.836 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.863 HD13 ' HA3' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.617 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.645 ' NE ' HG22 ' A' ' 482' ' ' ILE . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.548 ' O ' ' CB ' ' A' ' 491' ' ' PHE . 48.4 m0 -112.32 -80.73 0.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.548 ' CB ' ' O ' ' A' ' 490' ' ' TRP . 21.1 t80 80.29 -54.53 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 109.353 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.05 47.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.42 -36.41 63.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -1.171 . . . . 0.0 109.403 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.86 145.14 45.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.478 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -86.91 6.43 32.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.534 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.485 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 91.6 m-20 -107.98 133.87 51.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.305 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -121.49 145.88 43.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.783 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.684 HD13 ' CD1' ' A' ' 448' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 29.8 m120 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 444' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.783 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 434' ' ' LEU . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.789 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.567 ' C ' HG13 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 467' ' ' LEU . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.692 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.931 HG23 ' CB ' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.434 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.87 HD22 ' HD3' ' A' ' 477' ' ' LYS . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.831 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.87 ' HD3' HD22 ' A' ' 473' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.931 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 439' ' ' GLY . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.954 HD11 HD22 ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.789 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.692 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.613 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 -95.22 -84.94 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 24.7 m-85 -43.45 -38.24 2.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -55.27 -31.49 56.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 490' ' ' TRP . 91.6 m-20 -59.25 -34.91 72.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.144 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -34.07 71.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.477 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 58.27 39.77 25.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -1.12 . . . . 0.0 109.564 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 449' ' ' ALA . 50.8 m-20 -87.41 142.68 27.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -98.03 139.69 21.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.843 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.985 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.499 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.985 HG11 ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.833 HD22 HG22 ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.908 HD23 ' HG ' ' A' ' 434' ' ' LEU . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.709 HG13 ' C ' ' A' ' 458' ' ' ASP . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.442 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.709 ' C ' HG13 ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.668 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 478' ' ' ALA . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.744 HG22 ' NE ' ' A' ' 486' ' ' ARG . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.792 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.744 ' NE ' HG22 ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.478 ' O ' ' HA2' ' A' ' 492' ' ' GLY . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 457' ' ' GLU . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 -97.74 -85.25 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.41 -39.63 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 74.69 26.98 66.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.59 134.94 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -1.19 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.1 -34.76 79.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.476 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -55.18 -38.03 67.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 84.1 m-20 57.78 54.17 6.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.04 151.0 87.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.767 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.812 HD13 HD23 ' A' ' 448' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 444' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.734 ' O ' HD23 ' A' ' 444' ' ' LEU . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.767 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.548 ' HD3' HG23 ' A' ' 470' ' ' ILE . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.924 HD11 HD23 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.625 ' HD2' HD11 ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 458' ' ' ASP . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.833 HD11 ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.476 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.559 ' C ' HG13 ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.924 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.636 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 478' ' ' ALA . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 459' ' ' LEU . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.766 HD13 ' N ' ' A' ' 474' ' ' THR . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.725 ' HD3' HD22 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.727 ' HA ' HD11 ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.666 ' HD2' HG22 ' A' ' 482' ' ' ILE . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 -92.7 -85.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -48.85 -39.5 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.285 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.55 143.33 30.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.9 138.52 54.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.698 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 73.3 mm-40 -63.48 -33.35 75.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.96 -37.17 68.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -1.181 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.978 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 24.6 m120 -54.25 -36.97 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp -48.22 136.88 11.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.78 ' CD2' HD22 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 442' ' ' ARG . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.733 HG13 HD22 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.784 ' HA ' HD23 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.733 HD22 HG13 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.569 ' HA ' HD23 ' A' ' 434' ' ' LEU . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.673 ' CE ' HG23 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 1.002 HD11 HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.978 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.771 ' CD ' HD11 ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.822 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.482 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.641 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.034 HD11 HD21 ' A' ' 467' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 1.034 HD21 HD11 ' A' ' 459' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 464' ' ' ILE . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.771 HD11 ' CD ' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.424 ' H ' ' HE2' ' A' ' 447' ' ' LYS . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.598 HD12 ' HD3' ' A' ' 477' ' ' LYS . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.598 ' HD3' HD12 ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 1.016 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.64 ' CG1' HD22 ' A' ' 467' ' ' LEU . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.559 ' NE ' HG22 ' A' ' 482' ' ' ILE . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 -103.11 -90.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -49.94 -43.53 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -45.24 102.73 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -91.75 114.83 27.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -1.098 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.18 152.97 23.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.682 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.485 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 55.6 45.24 25.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 454' ' ' CYS . 0.9 OUTLIER 57.49 39.38 27.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.49 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -82.44 150.31 63.26 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.613 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.121 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 430' ' ' PRO . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.524 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.121 HG11 ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.853 ' O ' HD23 ' A' ' 444' ' ' LEU . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.613 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.492 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 1.018 HD11 HD13 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.658 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.93 ' HD2' HD11 ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.658 ' SG ' ' HB1' ' A' ' 449' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.673 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 437' ' ' LEU . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.644 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.018 HD13 HD11 ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.697 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.561 ' CD1' HD11 ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.93 HD11 ' HD2' ' A' ' 451' ' ' ARG . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.536 HD21 HD22 ' A' ' 481' ' ' LEU . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HG2' HD13 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.559 HD13 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.814 HG22 ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.814 ' NE ' HG22 ' A' ' 482' ' ' ILE . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 491' ' ' PHE . 25.9 m120 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 492' ' ' GLY . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 -96.17 -83.22 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 57.3 m-85 -47.27 -36.19 8.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.869 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 491' ' ' PHE . . . -49.87 -176.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.31 6.65 25.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -1.127 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 489' ' ' CYS . 77.4 tt0 -51.82 -33.68 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.31 -35.76 72.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -1.11 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -108.71 128.94 55.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -134.89 153.56 78.74 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.791 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.843 HD22 HD22 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 34.6 m120 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.653 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.756 HG11 ' CD2' ' A' ' 434' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.791 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.807 ' HD3' HD11 ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.755 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.885 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.686 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 482' ' ' ILE . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.807 HD11 ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.469 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 473' ' ' LEU . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.439 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.591 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 467' ' ' LEU . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.885 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.776 ' NE ' HG22 ' A' ' 482' ' ' ILE . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.883 ' SG ' HD23 ' A' ' 456' ' ' LEU . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 -94.99 -83.88 0.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -55.42 -39.07 69.79 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.349 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -79.7 142.9 25.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.66 115.59 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -1.146 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -56.17 142.59 36.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.447 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -58.28 -34.66 70.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 0.0 109.504 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.19 131.35 42.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -137.77 148.54 61.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.482 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.819 ' HG2' HD11 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.066 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 430' ' ' PRO . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.731 ' C ' HD21 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.066 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.89 HD22 HG22 ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 470' ' ' ILE . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.818 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 448' ' ' LEU . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.77 HD23 ' SG ' ' A' ' 489' ' ' CYS . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.436 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.557 ' HB3' HG13 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 467' ' ' LEU . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.507 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 459' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 447' ' ' LYS . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.975 HD21 ' HB2' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.975 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.81 HD22 HG23 ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 467' ' ' LEU . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 492' ' ' GLY . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.77 ' SG ' HD23 ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -93.6 -81.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 62.5 m-85 -56.69 -37.74 71.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.791 . . . . 0.0 109.264 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.97 -178.8 44.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 52.7 p30 -150.74 176.3 11.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -1.157 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -105.17 152.28 23.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.442 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.488 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -57.13 -36.43 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -1.096 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.438 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 87.6 m-20 -105.63 137.97 42.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp -122.93 146.1 47.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.636 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.048 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 33.8 m120 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.798 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.048 HG11 ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.775 HD22 HG22 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.78 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.988 ' HD2' HD11 ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 458' ' ' ASP . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.816 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.468 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.585 ' HB3' HG13 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 467' ' ' LEU . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.996 HG23 ' HB3' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.988 HD11 ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 473' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 1.039 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.673 HD11 HD12 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.816 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 -93.24 -84.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -50.74 -39.9 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 56.7 -134.38 51.67 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 48.16 36.32 6.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.184 -1.186 . . . . 0.0 109.38 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 495' ' ' ALA . 84.3 tt0 -62.63 -34.23 76.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.05 -36.76 70.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -107.24 135.09 49.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.37 141.8 31.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.595 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.781 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 1.024 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 430' ' ' PRO . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 456' ' ' LEU . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.024 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ASP . . . . . 0.477 ' HB2' HD13 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ASP . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.781 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 470' ' ' ILE . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.471 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.83 HD23 ' SG ' ' A' ' 489' ' ' CYS . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.536 ' OE2' ' HB1' ' A' ' 495' ' ' ALA . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.541 ' C ' HG13 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.888 HG23 ' CB ' ' A' ' 478' ' ' ALA . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 459' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.608 ' CG2' HD23 ' A' ' 473' ' ' LEU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 473' ' ' LEU . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.706 HD13 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.706 ' HD3' HD13 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.888 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.784 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 467' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.779 ' HA ' HD21 ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.83 ' SG ' HD23 ' A' ' 456' ' ' LEU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 -93.89 -84.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 14.8 m-85 -43.78 -41.97 5.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -80.2 132.13 11.08 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -96.46 6.61 48.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -1.147 . . . . 0.0 109.553 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.38 -33.2 74.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.536 ' HB1' ' OE2' ' A' ' 457' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.474 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -57.14 -34.22 68.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -1.168 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.478 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.9 m-20 -93.34 143.66 26.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER -109.93 149.91 40.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.308 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.739 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.848 ' CD2' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 33.9 m120 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 1.08 HD23 HG23 ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.751 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 1.08 HG23 HD23 ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.828 ' HD3' HG23 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 470' ' ' ILE . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.598 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . 0.534 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.803 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 459' ' ' LEU . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 478' ' ' ALA . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.828 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 473' ' ' LEU . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.751 HD13 ' HA3' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.745 HG12 HD21 ' A' ' 459' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.63 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.803 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.733 ' HD2' HG22 ' A' ' 482' ' ' ILE . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 492' ' ' GLY . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -97.91 -83.43 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -53.1 -38.79 62.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.473 -0.767 . . . . 0.0 109.274 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -58.78 123.76 34.45 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 494' ' ' GLU . 28.3 p-10 -67.55 -33.16 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -1.126 . . . . 0.0 109.293 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 493' ' ' ASP . 97.5 mt-10 -62.84 -32.88 74.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.83 -25.72 68.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -1.189 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ASN . . . . . 0.826 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 20.6 m120 -92.21 13.17 19.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm -64.67 150.64 93.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.69 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 432' ' ' ASP . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 442' ' ' ARG . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 432' ' ' ASP . 32.4 m120 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.563 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.773 HG11 ' HG ' ' A' ' 434' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.767 ' HA ' HD23 ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.69 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.674 ' HG2' HG23 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.87 HD12 HD23 ' A' ' 434' ' ' LEU . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.62 ' HD2' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.668 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.796 HD11 ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ASP . . . . . 0.668 ' C ' HG13 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 467' ' ' LEU . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLN . . . . . 0.575 ' CG ' HD22 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.674 HG23 ' HG2' ' A' ' 447' ' ' LYS . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 481' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.796 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.585 HD12 HG23 ' A' ' 440' ' ' VAL . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ALA . . . . . 0.796 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.768 ' HD2' HG22 ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 484' ' ' ALA . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' CYS . . . . . 0.698 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 -102.78 -83.93 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -46.25 -38.06 8.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -46.12 -42.35 12.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.28 -34.27 74.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -1.144 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -76.21 141.2 41.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.469 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.307 0.575 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.751 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.52 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.137 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 430' ' ' PRO . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.5 m-80 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 456' ' ' LEU . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.757 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.137 HG11 ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 444' ' ' LEU . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.751 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.773 ' CD1' HD13 ' A' ' 459' ' ' LEU . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.739 ' CD ' HD11 ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.869 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.576 ' HB2' HG12 ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.773 HD13 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.774 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 478' ' ' ALA . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.739 HD11 ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.581 HD12 ' HD3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 473' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.76 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.779 ' CD1' HG23 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.796 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.869 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.796 ' NE ' HG22 ' A' ' 482' ' ' ILE . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.848 ' SG ' HD23 ' A' ' 456' ' ' LEU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.145 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 430' ' ' PRO . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 73.0 m-80 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.757 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.145 HG11 ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 444' ' ' LEU . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 1.065 HD11 HD13 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.78 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.493 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.065 HD13 HD11 ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.509 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.868 HG23 ' CB ' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.627 ' CD1' HD11 ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.868 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.757 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.627 HD11 ' CD1' ' A' ' 467' ' ' LEU . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.78 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.699 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 484' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.574 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.586 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.923 HD22 HD12 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 61.7 m-80 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 456' ' ' LEU . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.819 ' HB3' HG13 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.694 ' HE3' HG22 ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.923 HD12 HD22 ' A' ' 434' ' ' LEU . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.783 HD11 ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.667 HG21 ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.83 HD12 ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.454 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.534 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 474' ' ' THR . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.628 ' CA ' HD11 ' A' ' 464' ' ' ILE . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.596 HG22 ' NE ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.528 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.783 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 483' ' ' MET . 85.1 m-20 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.351 0.596 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.673 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.74 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.541 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.713 HD13 HD12 ' A' ' 448' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 430' ' ' PRO . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 36.5 m-80 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 1.064 HD22 ' CD1' ' A' ' 456' ' ' LEU . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.863 HG13 HD22 ' A' ' 444' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.863 HD22 HG13 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 434' ' ' LEU . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.644 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.74 HG22 ' HB2' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 1.064 ' CD1' HD22 ' A' ' 437' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.644 ' C ' HG13 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.524 ' NE2' HG22 ' A' ' 453' ' ' VAL . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.63 HD11 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.566 HD23 ' HD3' ' A' ' 477' ' ' LYS . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 473' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.66 ' CD1' HG23 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 486' ' ' ARG . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.798 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.806 ' HD2' HG22 ' A' ' 482' ' ' ILE . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.8 m-20 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.58 HD12 ' CD1' ' A' ' 437' ' ' LEU . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.47 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.972 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.572 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.863 ' CD2' HD12 ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.895 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.2 m-80 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 456' ' ' LEU . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.73 ' O ' HD21 ' A' ' 481' ' ' LEU . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.84 HG13 HD22 ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.895 ' HA ' HD23 ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.972 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.863 HD12 ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.682 HG22 ' NE2' ' A' ' 462' ' ' GLN . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 437' ' ' LEU . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.534 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.615 ' C ' HG13 ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 459' ' ' LEU . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.682 ' NE2' HG22 ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 470' ' ' ILE . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.443 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 439' ' ' GLY . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.654 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.895 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.654 ' NE ' HG22 ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 437' ' ' LEU . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 456' ' ' LEU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.424 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.704 ' N ' ' HG ' ' A' ' 454' ' ' CYS . 29.8 tttp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.607 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 456' ' ' LEU . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 434' ' ' LEU . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 62.8 m-80 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 1.007 HD22 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.861 HG13 HD22 ' A' ' 444' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.861 HD22 HG13 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.678 ' HE2' HG23 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' A' ' 434' ' ' LEU . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.737 ' CD ' HD11 ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.704 ' HG ' ' N ' ' A' ' 429' ' ' LYS . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 1.007 ' CD1' HD22 ' A' ' 437' ' ' LEU . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.603 ' C ' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.775 HD11 HD21 ' A' ' 467' ' ' LEU . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.669 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.544 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.898 HG23 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.777 HD13 HD11 ' A' ' 482' ' ' ILE . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.943 ' HB ' HD12 ' A' ' 473' ' ' LEU . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.943 HD12 ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.451 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.898 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.777 HD11 HD13 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.845 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.669 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.358 0.599 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.866 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.56 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.667 ' CD2' HD22 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.2 m-80 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.7 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.597 HG13 HD22 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HA ' HD11 ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 444' ' ' LEU . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.866 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 434' ' ' LEU . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.868 HD11 ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.545 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.005 HD21 ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.604 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.474 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 478' ' ' ALA . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 473' ' ' LEU . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 1.047 ' CD2' ' HB2' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' A' ' 481' ' ' LEU . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 1.047 ' HB2' ' CD2' ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 1.005 ' HA ' HD21 ' A' ' 459' ' ' LEU . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.868 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.604 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.726 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 440' ' ' VAL . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.8 m-80 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 1.039 HD23 HG23 ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.863 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 444' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.727 ' HA ' HD23 ' A' ' 435' ' ' LEU . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.559 ' HD3' HG23 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.759 HD22 HD21 ' A' ' 434' ' ' LEU . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 430' ' ' PRO . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.505 ' HD2' HD11 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 431' ' ' ALA . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 459' ' ' LEU . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.559 HG23 ' HD3' ' A' ' 447' ' ' LYS . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 477' ' ' LYS . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' HD3' HD23 ' A' ' 473' ' ' LEU . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.836 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.863 HD13 ' HA3' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.617 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.645 ' NE ' HG22 ' A' ' 482' ' ' ILE . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.4 m0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.258 0.551 . . . . 0.0 109.748 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.783 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.684 HD13 ' CD1' ' A' ' 448' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.4 m-80 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 444' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.783 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 434' ' ' LEU . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.789 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.567 ' C ' HG13 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 467' ' ' LEU . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.692 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.931 HG23 ' CB ' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.434 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.87 HD22 ' HD3' ' A' ' 477' ' ' LYS . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.831 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.87 ' HD3' HD22 ' A' ' 473' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.931 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 439' ' ' GLY . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.954 HD11 HD22 ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.789 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.692 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.613 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.843 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.985 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.7 m-80 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.499 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.985 HG11 ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.833 HD22 HG22 ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.908 HD23 ' HG ' ' A' ' 434' ' ' LEU . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.709 HG13 ' C ' ' A' ' 458' ' ' ASP . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.442 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.709 ' C ' HG13 ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.668 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 478' ' ' ALA . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.744 HG22 ' NE ' ' A' ' 486' ' ' ARG . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.792 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.744 ' NE ' HG22 ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 457' ' ' GLU . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.304 0.573 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.767 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.812 HD13 HD23 ' A' ' 448' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.9 m-80 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 444' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 444' ' ' LEU . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.767 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.548 ' HD3' HG23 ' A' ' 470' ' ' ILE . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.924 HD11 HD23 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.625 ' HD2' HD11 ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 458' ' ' ASP . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.833 HD11 ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.476 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.559 ' C ' HG13 ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.924 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.636 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 478' ' ' ALA . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 459' ' ' LEU . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.766 HD13 ' N ' ' A' ' 474' ' ' THR . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.725 ' HD3' HD22 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.727 ' HA ' HD11 ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.666 ' HD2' HG22 ' A' ' 482' ' ' ILE . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.248 0.547 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.78 ' CD2' HD22 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 442' ' ' ARG . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 57.0 m-80 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.733 HG13 HD22 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.784 ' HA ' HD23 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.733 HD22 HG13 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.569 ' HA ' HD23 ' A' ' 434' ' ' LEU . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.673 ' CE ' HG23 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 1.002 HD11 HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.529 ' CB ' ' HD3' ' A' ' 430' ' ' PRO . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.771 ' CD ' HD11 ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.822 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.482 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.641 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.034 HD11 HD21 ' A' ' 467' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 1.034 HD21 HD11 ' A' ' 459' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 464' ' ' ILE . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.771 HD11 ' CD ' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.424 ' H ' ' HE2' ' A' ' 447' ' ' LYS . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.598 HD12 ' HD3' ' A' ' 477' ' ' LYS . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.598 ' HD3' HD12 ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 1.016 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.64 ' CG1' HD22 ' A' ' 467' ' ' LEU . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.559 ' NE ' HG22 ' A' ' 482' ' ' ILE . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.613 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.499 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.121 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 430' ' ' PRO . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 67.0 m-80 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.524 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.121 HG11 ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 444' ' ' LEU . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.613 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.492 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 1.018 HD11 HD13 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.658 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.93 ' HD2' HD11 ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.658 ' SG ' ' HB1' ' A' ' 449' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.673 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 437' ' ' LEU . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.644 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.018 HD13 HD11 ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.697 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.561 ' CD1' HD11 ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.93 HD11 ' HD2' ' A' ' 451' ' ' ARG . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.536 HD21 HD22 ' A' ' 481' ' ' LEU . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HG2' HD13 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.559 HD13 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.814 HG22 ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.543 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.814 ' NE ' HG22 ' A' ' 482' ' ' ILE . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.6 m-20 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.791 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.587 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.843 HD22 HD22 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 69.4 m-80 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.653 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.756 HG11 ' CD2' ' A' ' 434' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.791 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.807 ' HD3' HD11 ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.755 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.885 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.686 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 482' ' ' ILE . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.807 HD11 ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.469 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 473' ' ' LEU . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.439 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.591 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 467' ' ' LEU . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.885 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.776 ' NE ' HG22 ' A' ' 482' ' ' ILE . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.883 ' SG ' HD23 ' A' ' 456' ' ' LEU . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.819 ' HG2' HD11 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.066 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 430' ' ' PRO . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 72.5 m-80 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.731 ' C ' HD21 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.066 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.89 HD22 HG22 ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 470' ' ' ILE . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.818 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 448' ' ' LEU . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.77 HD23 ' SG ' ' A' ' 489' ' ' CYS . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.436 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.557 ' HB3' HG13 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 467' ' ' LEU . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.507 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 459' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 447' ' ' LYS . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.975 HD21 ' HB2' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.975 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.81 HD22 HG23 ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 467' ' ' LEU . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.77 ' SG ' HD23 ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.636 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.048 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 64.3 m-80 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.798 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.048 HG11 ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.775 HD22 HG22 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.78 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.988 ' HD2' HD11 ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 458' ' ' ASP . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.816 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.468 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.585 ' HB3' HG13 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 467' ' ' LEU . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.996 HG23 ' HB3' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.988 HD11 ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 473' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 1.039 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.673 HD11 HD12 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.816 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.781 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 1.024 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 430' ' ' PRO . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.7 m-80 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 456' ' ' LEU . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.024 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . 0.477 ' HB2' HD13 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.781 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 470' ' ' ILE . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.471 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.83 HD23 ' SG ' ' A' ' 489' ' ' CYS . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.487 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.541 ' C ' HG13 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.888 HG23 ' CB ' ' A' ' 478' ' ' ALA . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 459' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.608 ' CG2' HD23 ' A' ' 473' ' ' LEU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 473' ' ' LEU . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.706 HD13 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.706 ' HD3' HD13 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.888 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.784 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 467' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.779 ' HA ' HD21 ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.83 ' SG ' HD23 ' A' ' 456' ' ' LEU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.739 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.848 ' CD2' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 65.0 m-80 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 1.08 HD23 HG23 ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.751 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 1.08 HG23 HD23 ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.828 ' HD3' HG23 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 470' ' ' ILE . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.598 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 431' ' ' ALA . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . 0.534 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.803 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 459' ' ' LEU . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 478' ' ' ALA . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.828 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 473' ' ' LEU . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.751 HD13 ' HA3' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.745 HG12 HD21 ' A' ' 459' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.63 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.803 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.733 ' HD2' HG22 ' A' ' 482' ' ' ILE . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.69 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.556 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 442' ' ' ARG . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 60.8 m-80 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.563 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.773 HG11 ' HG ' ' A' ' 434' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ARG . . . . . 0.767 ' HA ' HD23 ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.69 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.674 ' HG2' HG23 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.87 HD12 HD23 ' A' ' 434' ' ' LEU . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.62 ' HD2' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.668 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.796 HD11 ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ASP . . . . . 0.668 ' C ' HG13 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 467' ' ' LEU . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLN . . . . . 0.575 ' CG ' HD22 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.674 HG23 ' HG2' ' A' ' 447' ' ' LYS . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 481' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.796 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.585 HD12 HG23 ' A' ' 440' ' ' VAL . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ALA . . . . . 0.796 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.768 ' HD2' HG22 ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 484' ' ' ALA . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' CYS . . . . . 0.698 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.34 -40.07 77.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -1.122 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.497 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 78.5 m-20 -53.4 -35.48 60.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 66.56 125.72 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.761 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.751 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 55.6 Cg_endo -76.31 151.42 33.76 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.851 2.367 . . . . 0.0 112.045 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -75.63 155.02 36.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.52 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 93.4 m-20 -51.96 -34.62 42.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 63.1 m-20 -58.99 -40.1 83.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.019 -1.051 . . . . 0.0 108.976 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.137 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -71.94 -43.76 64.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.468 -0.77 . . . . 0.0 109.471 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 430' ' ' PRO . 1.7 mt -68.74 -38.34 80.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.567 -0.708 . . . . 0.0 110.289 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.5 m-80 -88.12 -1.97 58.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 110.197 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.66 HD22 HD11 ' A' ' 456' ' ' LEU . 15.9 tp -73.78 126.43 30.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.027 -1.045 . . . . 0.0 109.485 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.12 134.97 57.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.3 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.757 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 106.86 -22.77 29.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.137 HG11 ' CD1' ' A' ' 434' ' ' LEU . 76.2 t -111.26 113.83 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.419 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -78.3 169.12 18.78 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -0.886 . . . . 0.0 109.006 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.0 ttt85 -54.43 -38.12 65.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.138 -0.977 . . . . 0.0 108.826 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.77 -56.29 14.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.572 -0.705 . . . . 0.0 109.976 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 444' ' ' LEU . 6.7 tt -52.62 -30.33 30.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.937 -1.102 . . . . 0.0 108.553 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.751 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -58.89 -42.51 89.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -75.16 -36.08 61.56 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 36.4 mttt -65.77 -28.89 69.35 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.773 ' CD1' HD13 ' A' ' 459' ' ' LEU . 2.7 tp -88.2 -43.97 11.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.453 -0.779 . . . . 0.0 109.266 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -64.32 -34.32 77.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.234 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.584 ' HB2' ' HA2' ' A' ' 426' ' ' GLY . . . -72.71 -3.51 25.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.163 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.739 ' CD ' HD11 ' A' ' 470' ' ' ILE . 4.5 mtp85 -108.29 13.0 26.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.0 110.037 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.44 -23.02 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 448' ' ' LEU . 0.2 OUTLIER -82.02 88.14 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 2.1 m -92.54 -3.87 54.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.5 p -137.16 158.54 44.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.047 -1.033 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.869 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.3 tp -59.78 -37.53 79.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.441 -0.787 . . . . 0.0 109.118 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.542 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 93.6 mt-10 -61.63 -39.64 92.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 108.963 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.576 ' HB2' HG12 ' A' ' 453' ' ' VAL . 92.0 m-20 -59.83 -31.9 70.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.47 -0.769 . . . . 0.0 109.074 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.773 HD13 ' CD1' ' A' ' 448' ' ' LEU . 30.3 tp -73.22 -34.54 65.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.23 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.774 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.49 -18.59 59.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 108.986 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -90.27 -13.51 35.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 56.5 mm-40 -78.51 160.58 27.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.499 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.95 154.77 16.33 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 478' ' ' ALA . 92.9 mt -50.13 -39.7 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.707 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -69.02 -35.37 76.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.564 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 87.0 m-20 -70.13 -40.09 75.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.9 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 482' ' ' ILE . 35.8 mt -84.11 -12.69 54.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -55.76 -32.56 63.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.07 -23.61 65.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.477 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.739 HD11 ' CD ' ' A' ' 451' ' ' ARG . 35.9 mm -58.27 160.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 0.0 109.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -103.51 134.36 47.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.39 -1.77 79.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.581 HD12 ' HD3' ' A' ' 477' ' ' LYS . 14.2 tp -105.05 133.36 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.57 167.65 9.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.587 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -63.81 -42.86 97.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.867 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.32 -41.73 63.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.886 . . . . 0.0 109.111 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.581 ' HD3' HD12 ' A' ' 473' ' ' LEU . 19.1 tttm -62.33 -42.18 99.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.047 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.76 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.02 -37.88 84.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.428 -0.795 . . . . 0.0 109.174 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.32 -35.75 92.35 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.9 -50.32 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -1.096 . . . . 0.0 109.237 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.779 ' CD1' HG23 ' A' ' 440' ' ' VAL . 3.0 mm? -51.97 -54.84 24.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.181 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.796 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.5 mt -62.79 -36.71 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 109.357 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 30.6 mtm -71.98 -29.97 64.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 108.974 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.43 -40.29 93.11 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.869 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.95 -38.25 61.76 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.796 ' NE ' HG22 ' A' ' 482' ' ' ILE . 76.6 mtt180 -65.44 -44.41 87.39 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -58.89 -42.33 89.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.825 . . . . 0.0 109.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.412 ' O ' ' HA2' ' A' ' 492' ' ' GLY . 81.4 mt -81.23 -34.91 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.933 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.848 ' SG ' HD23 ' A' ' 456' ' ' LEU . 40.4 m -81.4 -36.3 29.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 486' ' ' ARG . 50.3 m0 -94.01 -85.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.899 ' HB3' ' HB3' ' A' ' 495' ' ' ALA . 85.2 m-85 -47.49 -41.16 20.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.325 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 79.28 -166.07 51.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -65.1 -29.08 69.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -1.175 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.89 -34.32 8.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.35 -39.01 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -1.169 . . . . 0.0 109.427 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 450' ' ' ALA . 30.8 m120 57.4 43.28 23.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -90.62 139.95 26.53 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.52 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.4 Cg_endo -71.36 140.23 36.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.625 2.216 . . . . 0.0 111.788 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.581 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.48 159.67 29.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.04 -36.85 51.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.6 -40.89 89.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.987 -1.07 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.145 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -76.61 -41.66 45.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.439 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.662 HD11 ' HG2' ' A' ' 430' ' ' PRO . 6.4 mt -68.35 -35.29 77.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.16 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 73.0 m-80 -87.45 -1.38 57.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -66.06 128.07 34.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.014 -1.054 . . . . 0.0 109.358 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -61.67 -29.87 70.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.207 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.757 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -83.51 -1.27 90.2 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.145 HG11 ' CD1' ' A' ' 434' ' ' LEU . 93.8 t -124.98 121.95 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -1.071 . . . . 0.0 110.138 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -83.34 172.72 12.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -56.57 -43.07 79.64 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 108.831 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -70.01 -42.38 73.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.254 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 444' ' ' LEU . 4.6 tt -58.99 -30.16 67.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.875 -1.141 . . . . 0.0 109.401 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.38 -29.08 70.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -79.05 -49.22 13.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.141 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 470' ' ' ILE . 42.6 tttp -58.22 -33.1 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -0.926 . . . . 0.0 108.777 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 1.065 HD11 HD13 ' A' ' 459' ' ' LEU . 0.9 OUTLIER -82.01 -42.55 19.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -65.6 -33.9 76.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.432 -0.792 . . . . 0.0 109.038 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 428' ' ' ASN . . . -70.31 -12.35 61.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.009 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -95.4 15.91 18.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.787 . . . . 0.0 109.767 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.46 -18.99 55.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 449' ' ' ALA . 0.6 OUTLIER -83.56 78.37 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -1.183 . . . . 0.0 109.291 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.1 m -86.51 -2.39 58.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -139.02 151.97 47.24 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.116 -0.99 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.78 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.9 tp -55.77 -40.06 72.08 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.028 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.455 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -57.21 -38.22 73.39 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.493 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.8 m-20 -61.6 -35.01 76.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.065 HD13 HD11 ' A' ' 448' ' ' LEU . 32.5 tp -71.52 -36.77 71.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.699 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.71 -22.1 65.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -91.69 -10.79 38.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 109.955 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.509 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 73.5 mm-40 -71.38 -157.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -165.22 148.69 14.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.868 HG23 ' CB ' ' A' ' 478' ' ' ALA . 76.7 mt -45.7 -40.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -1.196 . . . . 0.0 109.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -70.16 -34.41 72.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 0.0 109.555 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.14 -42.37 62.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.379 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.627 ' CD1' HD11 ' A' ' 482' ' ' ILE . 20.6 mt -77.13 -22.68 52.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.58 -32.36 5.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.372 -0.83 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.29 -29.11 69.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.877 . . . . 0.0 109.3 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.458 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.7 mm -62.61 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.464 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -98.92 138.8 35.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.04 72.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -112.71 123.54 50.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.442 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.06 179.8 4.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.619 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.84 -40.12 95.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.539 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.94 -52.4 24.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.282 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' O ' HD23 ' A' ' 481' ' ' LEU . 21.6 mtpp -61.46 -38.3 86.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.868 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -53.82 -36.7 62.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.813 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -74.62 -74.17 0.88 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.16 -41.28 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.406 -1.055 . . . . 0.0 109.751 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.757 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -61.31 -66.86 0.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.397 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.627 HD11 ' CD1' ' A' ' 467' ' ' LEU . 84.9 mt -63.73 -32.0 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.551 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 90.7 mtp -65.64 -35.18 80.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -0.801 . . . . 0.0 109.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.12 -36.95 83.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.229 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.78 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.44 -45.43 38.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.022 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.699 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 98.3 mtt180 -64.11 -44.3 92.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.445 -0.784 . . . . 0.0 109.164 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 492' ' ' GLY . 90.3 m-20 -59.72 -38.52 81.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.549 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.624 ' O ' ' HB2' ' A' ' 495' ' ' ALA . 91.7 mt -80.97 -37.41 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.0 110.349 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.2 m -84.56 -28.24 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.13 -0.981 . . . . 0.0 109.773 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.574 ' CZ3' ' HD3' ' A' ' 486' ' ' ARG . 45.3 m0 -102.96 -85.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 0.0 109.731 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -46.11 -39.92 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -57.26 100.39 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.58 -32.61 74.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 495' ' ' ALA . 55.7 mp0 -62.08 -31.24 71.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -88.76 5.55 42.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.144 . . . . 0.0 109.571 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.43 ' C ' ' HG3' ' A' ' 429' ' ' LYS . 2.9 m120 -106.37 119.85 40.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.393 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -135.89 156.98 76.87 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.134 -0.979 . . . . 0.0 109.467 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.752 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 51.5 Cg_endo -72.0 142.71 39.11 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -75.43 150.72 38.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -0.901 . . . . 0.0 109.297 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.586 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 87.6 m-20 -50.83 -33.57 24.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.21 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.117 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.923 HD22 HD12 ' A' ' 448' ' ' LEU . 0.8 OUTLIER -76.66 -49.58 15.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 108.973 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.516 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.6 tp -52.44 -49.83 63.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.604 -0.685 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 61.7 m-80 -79.14 0.99 25.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.603 -0.686 . . . . 0.0 109.78 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.739 HD22 ' CD1' ' A' ' 456' ' ' LEU . 8.7 tp -68.74 121.53 16.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.67 -22.91 58.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.81 . . . . 0.0 110.135 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -82.65 -21.98 58.97 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 444' ' ' LEU . 87.7 t -119.61 117.84 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -1.173 . . . . 0.0 109.71 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.01 173.61 11.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.262 -0.899 . . . . 0.0 108.735 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -56.22 -43.73 78.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 108.609 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -64.37 -51.25 64.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.638 -0.664 . . . . 0.0 109.765 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.819 ' HB3' HG13 ' A' ' 440' ' ' VAL . 3.4 tt -55.15 -36.17 65.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.083 -1.01 . . . . 0.0 108.87 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.6 -32.1 58.16 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.57 -50.39 15.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.457 -0.777 . . . . 0.0 109.066 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.694 ' HE3' HG22 ' A' ' 470' ' ' ILE . 7.0 ttpm? -61.44 -30.27 70.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.84 . . . . 0.0 108.954 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.923 HD12 HD22 ' A' ' 434' ' ' LEU . 1.8 tm? -86.94 -41.3 14.05 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.345 -0.847 . . . . 0.0 109.067 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -67.9 -32.22 72.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.91 -0.35 13.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 470' ' ' ILE . 62.6 mtt-85 -104.6 14.04 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.799 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.29 -14.19 63.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 448' ' ' LEU . 1.3 t -89.71 58.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.193 . . . . 0.0 109.1 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 431' ' ' ALA . 73.3 m -68.43 -13.17 62.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.945 . . . . 0.0 110.689 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.448 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.1 p -121.94 150.16 42.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.69 -1.256 . . . . 0.0 110.219 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.783 HD11 ' CB ' ' A' ' 485' ' ' ALA . 10.0 tp -55.72 -40.13 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.429 -0.794 . . . . 0.0 108.932 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.17 -40.94 82.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 93.8 m-20 -57.04 -37.15 71.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.57 ' N ' ' CG1' ' A' ' 453' ' ' VAL . 19.6 tp -71.44 -38.96 71.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.309 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -58.49 -26.32 63.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.321 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 -13.9 49.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 57.6 mm-40 -75.96 161.57 28.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.141 -0.974 . . . . 0.0 109.471 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.94 155.75 19.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.667 HG21 ' OD1' ' A' ' 475' ' ' ASP . 96.1 mt -53.84 -39.75 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -1.19 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -66.63 -36.11 81.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 467' ' ' LEU . 57.4 t0 -66.72 -43.3 84.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.189 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 467' ' ' LEU . 7.4 mp -107.29 124.31 49.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.446 -0.784 . . . . 0.0 109.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -164.18 -34.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.746 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -84.79 8.17 18.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.895 . . . . 0.0 109.71 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.83 HD12 ' NE ' ' A' ' 451' ' ' ARG . 28.8 mm -63.5 163.01 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.169 -0.957 . . . . 0.0 109.455 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.454 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -87.55 127.5 35.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 76.05 15.83 81.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.534 ' CB ' ' HB ' ' A' ' 470' ' ' ILE . 15.0 tp -114.2 127.7 56.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.531 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.479 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.88 172.92 6.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.376 -0.827 . . . . 0.0 109.505 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 464' ' ' ILE . 49.8 t0 -65.5 -43.39 90.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -71.24 -38.34 71.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.193 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 474' ' ' THR . 84.4 tttt -65.78 -40.21 91.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -0.863 . . . . 0.0 109.11 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -63.39 -39.99 96.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.32 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.628 ' CA ' HD11 ' A' ' 464' ' ' ILE . . . -65.34 -38.65 95.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.1 -56.19 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -1.066 . . . . 0.0 109.401 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.7 mm? -48.63 -54.0 16.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.0 109.147 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.596 HG22 ' NE ' ' A' ' 486' ' ' ARG . 88.2 mt -63.02 -35.12 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.327 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.528 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 29.9 mtm -74.03 -28.66 61.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -62.85 -41.72 99.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.22 -0.925 . . . . 0.0 108.844 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.783 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -76.22 -35.63 58.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.395 -0.816 . . . . 0.0 108.97 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG3' ' HA ' ' A' ' 460' ' ' ALA . 91.6 mtt180 -65.9 -44.66 84.57 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 483' ' ' MET . 85.1 m-20 -62.18 -38.43 89.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 484' ' ' ALA . 86.8 mt -73.29 -35.2 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -91.31 -21.89 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 486' ' ' ARG . 47.1 m0 -101.95 -87.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 0.0 109.778 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -53.63 -40.66 65.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.665 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 71.59 -124.69 10.94 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.35 -34.87 72.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 109.425 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 97.2 mt-10 -63.03 -33.53 75.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.4 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.465 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.35 -38.12 68.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -1.141 . . . . 0.0 109.577 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.476 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.7 m-20 -74.52 147.51 41.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.423 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mtmt -126.98 147.89 63.42 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.762 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.673 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.96 142.25 42.19 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.881 2.388 . . . . 0.0 112.213 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.74 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -78.96 160.32 27.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.795 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.541 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.9 m-20 -51.51 -38.38 53.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.331 -0.855 . . . . 0.0 109.939 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 30.8 m-20 -60.06 -33.7 72.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.982 -1.074 . . . . 0.0 109.247 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.713 HD13 HD12 ' A' ' 448' ' ' LEU . 16.3 mt -81.87 -33.98 30.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.807 . . . . 0.0 109.291 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.578 HD21 ' HG2' ' A' ' 430' ' ' PRO . 2.2 mm? -74.27 -39.24 63.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.785 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 36.5 m-80 -88.5 -6.32 57.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 110.258 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 1.064 HD22 ' CD1' ' A' ' 456' ' ' LEU . 53.8 tp -65.3 125.4 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.996 -1.065 . . . . 0.0 109.619 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.43 134.01 53.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 107.31 -21.98 29.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.863 HG13 HD22 ' A' ' 444' ' ' LEU . 97.6 t -120.26 110.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -1.187 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 5.5 p30 -77.71 175.95 9.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.572 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 31.4 ttt85 -59.07 -37.47 77.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.368 -0.832 . . . . 0.0 109.08 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.27 -57.38 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.781 . . . . 0.0 109.774 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.863 HD22 HG13 ' A' ' 440' ' ' VAL . 7.0 tt -54.58 -26.97 35.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.09 -1.006 . . . . 0.0 108.976 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.33 -31.37 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.327 -0.858 . . . . 0.0 109.126 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -73.57 -51.06 18.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.011 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 43.5 tttm -62.05 -32.55 73.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 108.934 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 434' ' ' LEU . 2.1 tm? -81.64 -43.65 18.27 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.54 69.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.08 -8.13 42.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 28.5 mmt85 -99.31 16.1 24.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.06 -22.92 33.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.644 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.6 t -79.74 69.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -1.138 . . . . 0.0 108.72 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.581 ' O ' ' N ' ' A' ' 431' ' ' ALA . 7.6 m -80.92 -3.87 52.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 110.605 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.74 HG22 ' HB2' ' A' ' 431' ' ' ALA . 4.3 p -136.07 157.21 47.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.719 -1.238 . . . . 0.0 110.102 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 1.064 ' CD1' HD22 ' A' ' 437' ' ' LEU . 6.3 tp -58.48 -41.06 84.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -56.58 -39.13 72.98 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.644 ' C ' HG13 ' A' ' 453' ' ' VAL . 81.2 m-20 -66.66 -35.03 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.3 tm? -71.36 -39.52 71.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 108.865 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.55 -28.06 66.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 108.871 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.36 -10.88 59.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.646 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.524 ' NE2' HG22 ' A' ' 453' ' ' VAL . 49.6 mm-40 -78.41 163.25 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.604 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.03 20.54 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.4 mt -52.39 -37.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -1.216 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.55 -38.41 80.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.626 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.1 -46.2 65.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.63 HD11 ' CG1' ' A' ' 482' ' ' ILE . 17.1 mt -63.62 -31.67 72.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.241 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -43.95 -33.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 0.0 109.389 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.08 -29.93 70.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 467' ' ' LEU . 23.4 mm -67.3 162.33 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.6 tt0 -108.37 142.49 38.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.371 -0.831 . . . . 0.0 109.456 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.13 7.89 67.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.566 HD23 ' HD3' ' A' ' 477' ' ' LYS . 11.2 mt -114.15 136.16 53.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -1.136 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.1 171.09 7.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.618 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -64.16 -44.06 93.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.533 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.26 -43.19 61.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 473' ' ' LEU . 56.3 tttp -59.84 -41.76 92.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.073 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -61.76 -35.82 79.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.455 -0.778 . . . . 0.0 109.298 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -65.19 -34.77 90.5 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.94 -51.45 9.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -1.092 . . . . 0.0 109.365 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.66 ' CD1' HG23 ' A' ' 440' ' ' VAL . 4.3 mm? -51.45 -59.71 3.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.329 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 486' ' ' ARG . 90.3 mt -60.57 -33.41 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 4.1 mmm -74.89 -32.76 61.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.33 -39.46 85.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.167 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.798 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -71.87 -44.83 63.13 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.806 ' HD2' HG22 ' A' ' 482' ' ' ILE . 43.8 mtt180 -65.22 -45.05 86.27 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.535 -0.728 . . . . 0.0 109.3 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 483' ' ' MET . 84.8 m-20 -61.46 -28.93 69.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.736 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.58 HD12 ' CD1' ' A' ' 437' ' ' LEU . 91.6 mt -90.93 -25.1 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 495' ' ' ALA . 0.1 OUTLIER -100.37 -19.62 16.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.47 ' N ' ' O ' ' A' ' 486' ' ' ARG . 48.7 m0 -108.67 -93.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.713 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -48.3 -44.45 33.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.677 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -55.42 125.36 36.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.9 -37.07 85.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -1.158 . . . . 0.0 109.203 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 84.3 tt0 -57.92 -32.95 68.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.401 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.508 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 55.39 43.2 29.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -1.192 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.442 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 92.6 m-20 -100.36 132.21 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -132.02 154.23 81.63 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.972 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 48.7 Cg_endo -69.3 139.19 41.2 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.738 2.292 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -78.61 149.05 33.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.493 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.572 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.5 m-20 -54.11 -30.62 49.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.924 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 78.9 m-20 -59.38 -43.95 92.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.863 ' CD2' HD12 ' A' ' 448' ' ' LEU . 10.7 tp -73.25 -51.9 15.98 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.696 0.76 . . . . 0.0 109.298 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.895 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.2 mt -53.88 -41.01 67.07 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.595 -0.691 . . . . 0.0 109.954 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.2 m-80 -89.2 -0.36 57.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.924 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 456' ' ' LEU . 39.0 tp -80.04 122.52 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.287 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.3 136.89 48.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.163 -0.961 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.73 ' O ' HD21 ' A' ' 481' ' ' LEU . . . 107.05 -21.44 31.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.84 HG13 HD22 ' A' ' 444' ' ' LEU . 84.5 t -123.83 112.78 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -1.2 . . . . 0.0 109.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -78.38 167.65 21.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.338 -0.851 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.895 ' HA ' HD23 ' A' ' 435' ' ' LEU . 55.0 ttm-85 -54.92 -35.95 64.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.093 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -68.58 -47.46 66.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.548 -0.72 . . . . 0.0 109.892 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.1 tt -60.49 -28.53 68.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.206 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.972 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -63.53 -28.06 69.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -74.32 -53.85 8.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 108.825 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 26.8 tttm -58.21 -36.34 72.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 108.604 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.863 HD12 ' CD2' ' A' ' 434' ' ' LEU . 1.8 tm? -78.75 -41.0 31.83 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 445' ' ' ALA . . . -70.67 -30.67 67.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.361 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -71.34 -6.96 43.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 46.5 mmt180 -99.31 16.01 24.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.8 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.85 -17.64 55.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.682 HG22 ' NE2' ' A' ' 462' ' ' GLN . 38.8 t -83.4 64.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -1.091 . . . . 0.0 108.947 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 6.6 m -76.8 -5.11 46.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.665 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 3.8 p -129.3 155.81 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.693 -1.254 . . . . 0.0 110.396 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 437' ' ' LEU . 4.5 tp -58.98 -38.32 78.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.708 ' OE2' ' HB1' ' A' ' 495' ' ' ALA . 94.0 mt-10 -59.66 -39.02 83.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.615 ' C ' HG13 ' A' ' 453' ' ' VAL . 84.2 m-20 -64.09 -33.05 74.87 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 459' ' ' LEU . 3.4 tm? -73.77 -36.46 65.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 108.957 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -63.07 -25.18 68.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.831 . . . . 0.0 109.067 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -82.23 -8.75 59.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.682 ' NE2' HG22 ' A' ' 453' ' ' VAL . 45.7 mm-40 -78.05 159.57 28.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -118.51 149.63 18.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -49.0 -39.06 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.63 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -69.73 -37.9 76.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 91.3 m-20 -67.93 -46.54 71.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 482' ' ' ILE . 15.1 mt -63.81 -31.56 72.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.253 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.06 -32.88 1.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.402 -0.811 . . . . 0.0 109.339 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.0 -30.21 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 467' ' ' LEU . 22.1 mm -68.38 166.27 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 0.0 109.519 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.5 tt0 -106.34 139.94 40.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.34 7.09 67.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 470' ' ' ILE . 11.4 mt -115.99 140.71 48.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -1.179 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.443 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -113.4 166.34 11.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 109.486 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 90.0 m-20 -59.7 -50.92 71.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.575 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.86 -42.34 67.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.405 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.633 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.3 tttp -60.8 -42.1 96.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.923 . . . . 0.0 109.221 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.826 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.12 -38.53 91.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.019 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.02 -36.51 81.57 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.471 ' HA ' ' HE3' ' A' ' 483' ' ' MET . . . -76.27 -61.31 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -1.06 . . . . 0.0 109.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 439' ' ' GLY . 5.8 mp -47.87 -51.82 21.57 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.911 . . . . 0.0 108.953 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.654 HG22 ' NE ' ' A' ' 486' ' ' ARG . 77.1 mt -61.19 -34.57 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.392 -0.818 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 17.5 mtm -76.33 -29.71 57.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.41 -43.0 86.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 108.913 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.895 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -73.82 -35.32 64.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.654 ' NE ' HG22 ' A' ' 482' ' ' ILE . 29.9 mtt180 -68.58 -43.59 76.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 491' ' ' PHE . 84.9 m-20 -59.57 -40.77 88.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.467 -0.771 . . . . 0.0 109.591 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 437' ' ' LEU . 80.0 mt -78.88 -39.93 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.784 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 456' ' ' LEU . 17.5 m -76.58 -34.17 58.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.837 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.424 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 44.3 m0 -96.7 -83.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.436 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 60.5 m-85 -46.06 -38.96 8.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.069 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -86.42 115.71 4.28 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.79 -40.22 87.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.146 . . . . 0.0 109.431 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -59.08 143.52 48.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.708 ' HB1' ' OE2' ' A' ' 457' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.537 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 428' ' ' ASN . 27.0 p-10 -62.71 -33.74 75.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -1.177 . . . . 0.0 109.456 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 427' ' ' ASP . 80.4 m-20 -113.69 135.81 53.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.538 ' CG ' ' HD2' ' A' ' 430' ' ' PRO . 29.8 tttp -141.74 140.73 20.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.607 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.1 Cg_endo -70.15 136.41 31.9 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.764 2.309 . . . . 0.0 111.973 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.67 161.61 28.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.3 m-20 -52.84 -37.26 59.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.89 . . . . 0.0 109.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 456' ' ' LEU . 76.4 m-20 -59.77 -42.42 93.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.953 -1.092 . . . . 0.0 108.934 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 434' ' ' LEU . 0.9 OUTLIER -73.54 -43.62 59.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 430' ' ' PRO . 8.4 mt -65.68 -39.28 91.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.611 -0.681 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 62.8 m-80 -88.56 -3.69 58.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.948 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 1.007 HD22 ' CD1' ' A' ' 456' ' ' LEU . 32.5 tp -61.89 140.53 58.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.128 -0.983 . . . . 0.0 109.546 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.15 131.63 36.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 481' ' ' LEU . . . 106.06 -17.52 41.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.861 HG13 HD22 ' A' ' 444' ' ' LEU . 97.8 t -114.72 113.4 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.383 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -77.95 170.29 16.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -0.906 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -56.03 -38.16 70.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.837 . . . . 0.0 108.956 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.58 -50.2 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 109.688 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.861 HD22 HG13 ' A' ' 440' ' ' VAL . 5.9 tt -57.89 -28.82 64.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.124 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -62.81 -32.36 73.53 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.3 -0.875 . . . . 0.0 108.824 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -73.71 -52.5 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.357 -0.839 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.678 ' HE2' HG23 ' A' ' 470' ' ' ILE . 16.2 tttt -60.27 -34.7 74.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.903 . . . . 0.0 108.726 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' A' ' 434' ' ' LEU . 2.1 tm? -78.2 -43.19 29.16 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.57 67.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 109.49 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.39 -11.14 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.575 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.737 ' CD ' HD11 ' A' ' 470' ' ' ILE . 40.7 mtp180 -96.47 16.76 17.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.2 -12.94 67.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.7 t -86.94 64.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 109.222 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 431' ' ' ALA . 96.0 m -77.81 -7.81 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.09 -1.006 . . . . 0.0 110.323 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.5 p -126.36 146.8 49.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.927 -1.108 . . . . 0.0 110.015 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 1.007 ' CD1' HD22 ' A' ' 437' ' ' LEU . 3.5 tp -52.36 -40.49 62.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.511 -0.743 . . . . 0.0 109.007 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 27.7 tt0 -57.83 -40.29 79.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 108.826 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.603 ' C ' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -57.9 -34.22 69.59 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.775 HD11 HD21 ' A' ' 467' ' ' LEU . 18.1 tp -73.19 -33.19 65.26 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.42 -0.8 . . . . 0.0 108.888 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.669 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -61.81 -28.0 69.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 108.907 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.56 -8.92 59.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.474 -0.766 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.544 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 34.8 mm-40 -80.76 163.21 23.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -125.03 158.34 19.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.898 HG23 ' HB3' ' A' ' 478' ' ' ALA . 78.2 mt -48.13 -40.56 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -1.178 . . . . 0.0 109.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.54 -37.36 79.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.862 . . . . 0.0 109.759 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 462' ' ' GLN . 57.8 t0 -64.02 -48.12 77.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.777 HD13 HD11 ' A' ' 482' ' ' ILE . 10.7 mp -72.33 -23.29 61.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.24 14.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.628 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -28.37 70.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.943 ' HB ' HD12 ' A' ' 473' ' ' LEU . 30.1 mm -66.12 159.1 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.389 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -98.36 140.3 32.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.6 7.17 72.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.943 HD12 ' HB ' ' A' ' 470' ' ' ILE . 7.5 mt -109.39 135.08 51.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -1.143 . . . . 0.0 109.433 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.451 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -111.89 171.18 7.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.727 -179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.88 -40.85 96.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.21 -47.89 32.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.159 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 481' ' ' LEU . 70.0 tttt -59.13 -40.05 84.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.271 -0.893 . . . . 0.0 109.079 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.898 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -53.59 -40.45 65.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 483' ' ' MET . . . -68.37 -74.52 0.59 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.94 -48.22 2.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.486 -1.008 . . . . 0.0 109.918 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 439' ' ' GLY . 3.4 mm? -58.79 -68.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.211 -0.93 . . . . 0.0 109.797 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.777 HD11 HD13 ' A' ' 467' ' ' LEU . 79.9 mt -59.92 -30.16 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.535 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 82.2 mtp -67.5 -31.75 72.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.449 -0.782 . . . . 0.0 109.414 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.37 -38.63 81.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.195 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.845 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -74.0 -39.8 63.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.286 -0.884 . . . . 0.0 108.884 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.669 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -68.64 -44.11 74.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.448 -0.783 . . . . 0.0 109.006 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 483' ' ' MET . 90.4 m-20 -60.24 -36.45 77.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 484' ' ' ALA . 70.5 mt -83.59 -40.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.745 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -75.69 -28.76 58.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.852 . . . . 0.0 109.465 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.3 m0 -101.69 -83.05 0.46 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.644 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -52.7 -38.61 60.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.424 -0.797 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -84.33 -171.18 47.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 57.6 p30 -135.64 176.23 8.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -1.107 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -101.57 151.23 22.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.501 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.643 ' HA2' ' HB2' ' A' ' 450' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -57.01 -40.71 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.493 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 83.4 m-20 -52.32 -39.73 60.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.92 . . . . 0.0 109.33 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 428' ' ' ASN . 0.2 OUTLIER 73.03 131.4 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.866 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 55.2 Cg_endo -87.24 155.28 8.15 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.039 2.492 . . . . 0.0 112.048 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -72.88 151.74 41.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 109.29 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.56 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 92.9 m-20 -53.14 -31.67 43.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.219 -0.925 . . . . 0.0 109.527 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 66.6 m-20 -59.08 -42.18 89.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.027 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.667 ' CD2' HD22 ' A' ' 448' ' ' LEU . 4.1 tp -75.78 -51.83 11.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.447 -0.783 . . . . 0.0 109.027 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.533 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 12.0 tp -50.95 -50.14 58.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.506 0.67 . . . . 0.0 109.397 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.2 m-80 -80.06 -0.08 34.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 109.759 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 433' ' ' ASP . 8.1 tp -70.59 127.04 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.74 -23.21 63.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.7 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -85.25 -20.06 57.76 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.597 HG13 HD22 ' A' ' 444' ' ' LEU . 92.2 t -118.12 113.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.866 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -76.86 175.96 8.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.365 -0.834 . . . . 0.0 108.813 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.504 ' HA ' HD11 ' A' ' 435' ' ' LEU . 15.8 ttt180 -56.99 -46.33 82.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.139 -0.975 . . . . 0.0 108.424 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 -51.48 61.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.529 -0.732 . . . . 0.0 109.768 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 444' ' ' LEU . 4.8 tt -55.63 -32.15 62.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.978 -1.076 . . . . 0.0 108.958 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.866 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.074 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.33 -44.34 62.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.816 . . . . 0.0 108.948 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 470' ' ' ILE . 17.2 tptt -59.95 -38.36 82.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.875 . . . . 0.0 108.814 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 434' ' ' LEU . 1.1 tp -75.73 -48.85 20.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.853 . . . . 0.0 109.011 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -58.1 -39.54 78.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.643 ' HB2' ' HA2' ' A' ' 426' ' ' GLY . . . -75.4 -2.87 30.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 108.994 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 451' ' ' ARG . 38.5 tpt85 -101.21 11.49 39.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 109.592 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.81 64.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.576 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.4 OUTLIER -95.05 96.49 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.202 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 7.3 m -99.74 -7.72 25.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 0.0 109.852 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.7 p -132.77 155.04 49.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.113 -0.992 . . . . 0.0 109.811 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.868 HD11 ' CB ' ' A' ' 485' ' ' ALA . 28.9 tp -55.79 -38.96 70.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.135 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.55 -42.59 92.74 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.283 -0.885 . . . . 0.0 108.949 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.545 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -59.56 -34.13 72.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.4 -0.813 . . . . 0.0 108.93 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.005 HD21 ' HA ' ' A' ' 482' ' ' ILE . 6.6 tt -74.12 -36.72 64.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.051 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.604 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -58.65 -25.49 62.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.027 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.49 -10.3 57.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.406 -0.808 . . . . 0.0 109.629 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.474 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 47.1 mm-40 -80.88 161.29 24.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.173 -0.954 . . . . 0.0 109.572 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -125.51 158.48 19.87 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 478' ' ' ALA . 84.8 mt -50.34 -38.32 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -1.145 . . . . 0.0 109.695 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.14 -38.15 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.801 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 84.1 m-20 -68.07 -47.88 67.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.387 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.619 ' HB3' HD13 ' A' ' 473' ' ' LEU . 15.9 mt -64.73 -29.46 70.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 467' ' ' LEU . . . -44.25 -34.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.15 -28.52 69.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 447' ' ' LYS . 30.1 mm -64.78 164.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -108.13 137.03 46.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.5 -1.27 75.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 1.047 ' CD2' ' HB2' ' A' ' 478' ' ' ALA . 6.6 tt -106.39 134.51 49.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.518 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -107.14 167.13 10.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.61 -46.12 91.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.31 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -67.7 -41.91 82.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' A' ' 481' ' ' LEU . 37.3 tttt -61.66 -44.79 96.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 1.047 ' HB2' ' CD2' ' A' ' 473' ' ' LEU . . . -63.04 -37.63 87.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.531 ' O ' ' CG ' ' A' ' 483' ' ' MET . . . -58.71 -40.71 95.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.86 -49.0 11.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -1.109 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -56.05 -52.76 63.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 1.005 ' HA ' HD21 ' A' ' 459' ' ' LEU . 87.0 mt -65.26 -32.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.546 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 6.6 mtp -75.74 -33.59 60.27 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.475 -0.766 . . . . 0.0 109.41 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -67.21 -40.85 86.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.158 -0.964 . . . . 0.0 109.137 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.868 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.86 -45.68 57.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -0.813 . . . . 0.0 109.074 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.604 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 91.9 mtt180 -61.62 -42.04 98.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.6 m-20 -63.82 -30.35 71.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.754 . . . . 0.0 109.455 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 484' ' ' ALA . 85.9 mt -90.89 -32.52 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.054 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.4 m -84.2 -28.94 26.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.819 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.9 m0 -99.75 -85.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -57.7 -43.1 84.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.377 -0.827 . . . . 0.0 109.694 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -87.54 -179.97 47.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -98.95 163.96 12.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -1.144 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.437 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.53 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -55.05 -38.72 68.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -1.131 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 449' ' ' ALA . 88.4 m-20 -105.12 127.16 52.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 1.0 OUTLIER -122.39 135.82 25.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.427 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.726 ' CG ' ' HB1' ' A' ' 445' ' ' ALA . 50.4 Cg_endo -71.23 144.76 47.17 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.749 2.299 . . . . 0.0 111.944 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.62 156.5 32.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.597 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 94.1 m-20 -53.93 -33.57 57.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.886 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.24 -38.86 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.992 -1.068 . . . . 0.0 109.153 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 440' ' ' VAL . 6.0 tp -78.3 -50.46 11.77 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.412 -0.805 . . . . 0.0 109.207 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 442' ' ' ARG . 1.8 mt -56.38 -40.4 74.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.556 -0.715 . . . . 0.0 109.894 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.8 m-80 -85.03 -0.45 54.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.964 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 1.039 HD23 HG23 ' A' ' 440' ' ' VAL . 17.7 tp -64.88 132.87 50.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.58 -26.07 68.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.389 -0.82 . . . . 0.0 109.764 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.863 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -93.16 -4.75 64.41 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 444' ' ' LEU . 40.6 t -124.83 121.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.985 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -91.63 173.58 7.81 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.727 ' HA ' HD23 ' A' ' 435' ' ' LEU . 53.2 ttt85 -55.97 -42.43 76.28 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 108.564 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.85 -50.81 63.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.63 -0.669 . . . . 0.0 109.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 440' ' ' VAL . 8.4 tt -59.55 -23.23 62.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.046 -1.034 . . . . 0.0 109.254 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.726 ' HB1' ' CG ' ' A' ' 430' ' ' PRO . . . -68.72 -28.22 66.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.351 -0.843 . . . . 0.0 108.955 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -76.58 -48.01 20.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.369 -0.832 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.559 ' HD3' HG23 ' A' ' 470' ' ' ILE . 51.3 tttp -61.79 -36.11 80.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.759 HD22 HD21 ' A' ' 434' ' ' LEU . 0.6 OUTLIER -80.81 -38.23 28.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 428' ' ' ASN . . . -71.13 -36.22 72.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 428' ' ' ASN . . . -71.7 -7.92 51.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.505 ' HD2' HD11 ' A' ' 470' ' ' ILE . 51.3 mtt-85 -101.43 15.79 27.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 96.03 -21.35 45.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.582 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.5 OUTLIER -85.56 69.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -1.143 . . . . 0.0 109.244 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 431' ' ' ALA . 86.3 m -85.49 -2.3 57.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.835 . . . . 0.0 109.631 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.448 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 2.5 p -132.78 151.89 51.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.053 -1.03 . . . . 0.0 109.81 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 485' ' ' ALA . 16.0 tp -55.11 -39.67 69.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.411 -0.805 . . . . 0.0 109.07 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.21 -44.03 92.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.036 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 85.5 m-20 -55.5 -37.45 67.86 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 459' ' ' LEU . 1.1 tt -69.51 -41.22 76.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.481 -0.762 . . . . 0.0 109.328 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.573 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -57.0 -21.64 32.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.93 . . . . 0.0 109.254 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.4 tt0 -89.36 -11.1 44.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.334 -0.854 . . . . 0.0 109.572 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 55.3 mm-40 -80.68 160.43 25.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.417 ' H ' ' HB2' ' A' ' 466' ' ' ASP . . . -117.98 155.88 15.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.836 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.5 mt -48.81 -41.17 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -1.14 . . . . 0.0 109.885 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -68.32 -36.17 78.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.896 . . . . 0.0 109.778 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 463' ' ' GLY . 81.8 m-20 -70.31 -40.49 74.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 482' ' ' ILE . 42.8 mt -81.06 -18.39 46.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.19 -35.6 7.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -66.42 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.559 HG23 ' HD3' ' A' ' 447' ' ' LYS . 31.7 mm -60.82 159.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.847 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.3 tt0 -104.32 138.95 40.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.332 -0.855 . . . . 0.0 109.485 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.25 2.63 73.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 477' ' ' LYS . 10.7 mt -118.03 135.96 53.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -1.136 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -105.04 171.64 7.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.11 -40.28 95.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.439 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -76.56 -44.9 32.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.286 -0.884 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' HD3' HD23 ' A' ' 473' ' ' LEU . 23.5 tttp -62.32 -37.57 86.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.836 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.05 -41.39 99.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.848 . . . . 0.0 109.097 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.617 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -62.69 -34.88 90.91 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.98 -55.82 4.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -1.072 . . . . 0.0 108.838 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.863 HD13 ' HA3' ' A' ' 439' ' ' GLY . 11.6 tp -49.7 -58.23 5.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.003 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 467' ' ' LEU . 63.5 mt -55.99 -36.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 109.06 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.617 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 22.3 mtm -75.09 -27.74 60.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.27 -0.894 . . . . 0.0 108.995 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.81 -42.69 85.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.95 -40.58 65.27 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.645 ' NE ' HG22 ' A' ' 482' ' ' ILE . 38.4 mtt180 -63.05 -41.04 99.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.0 m-20 -63.09 -33.71 76.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.64 -0.662 . . . . 0.0 109.273 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 484' ' ' ALA . 73.3 mt -84.32 -42.28 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 0.0 109.711 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.97 -33.34 33.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.548 ' O ' ' CB ' ' A' ' 491' ' ' PHE . 48.4 m0 -112.32 -80.73 0.59 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.0 109.695 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.548 ' CB ' ' O ' ' A' ' 490' ' ' TRP . 21.1 t80 80.29 -54.53 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.392 -0.818 . . . . 0.0 109.353 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.05 47.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.42 -36.41 63.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -1.171 . . . . 0.0 109.403 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.86 145.14 45.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.478 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -86.91 6.43 32.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.534 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.485 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 91.6 m-20 -107.98 133.87 51.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.305 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -121.49 145.88 43.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.783 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 54.8 Cg_endo -73.38 139.2 28.52 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.769 2.312 . . . . 0.0 111.886 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -74.84 158.29 33.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 86.9 m-20 -50.68 -37.51 41.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 58.1 m-20 -64.68 -37.01 86.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.084 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.684 HD13 ' CD1' ' A' ' 448' ' ' LEU . 23.5 mt -80.41 -35.66 34.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.378 -0.826 . . . . 0.0 109.123 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.657 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.8 tp -71.98 -44.34 63.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.543 -0.723 . . . . 0.0 109.755 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 51.4 m-80 -83.32 0.48 45.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.384 -0.822 . . . . 0.0 109.722 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 481' ' ' LEU . 16.0 tp -65.44 126.29 27.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.485 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.55 -24.46 66.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.11 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -84.43 -21.85 55.5 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 444' ' ' LEU . 54.1 t -114.62 113.83 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.143 . . . . 0.0 109.219 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -75.64 172.02 13.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.254 -0.904 . . . . 0.0 108.81 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 39.4 ttm105 -53.8 -46.74 71.16 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -67.31 -47.87 69.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.699 -0.626 . . . . 0.0 109.777 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 440' ' ' VAL . 6.0 tt -58.92 -30.02 67.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.024 -1.048 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.783 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.19 -32.07 71.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 450' ' ' ALA . 74.8 m-85 -74.86 -55.11 6.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.901 . . . . 0.0 108.718 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 451' ' ' ARG . 29.8 tttp -56.05 -37.54 69.39 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 434' ' ' LEU . 1.8 tm? -74.79 -42.99 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -69.43 -31.76 70.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.229 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 446' ' ' PHE . . . -71.8 -5.97 38.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.539 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 447' ' ' LYS . 37.8 mmt180 -98.4 15.49 24.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 94.78 -17.0 60.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -89.35 75.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.05 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.543 ' O ' ' N ' ' A' ' 431' ' ' ALA . 63.9 m -83.38 -9.12 59.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.073 -1.017 . . . . 0.0 110.047 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.6 p -132.65 155.27 49.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 109.775 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.789 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 6.1 tp -56.42 -41.14 75.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.363 -0.836 . . . . 0.0 108.881 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 94.4 mt-10 -57.01 -40.92 77.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.0 108.846 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.567 ' C ' HG13 ' A' ' 453' ' ' VAL . 91.8 m-20 -62.78 -33.53 75.38 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 467' ' ' LEU . 0.2 OUTLIER -71.33 -36.12 71.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 109.116 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.692 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.68 -26.62 65.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -0.887 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.86 -9.87 58.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.731 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 57.2 mm-40 -81.71 162.36 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.56 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -121.53 155.92 16.5 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.931 HG23 ' CB ' ' A' ' 478' ' ' ALA . 67.2 mt -48.94 -41.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -1.191 . . . . 0.0 109.791 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.9 -38.45 88.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.89 -50.68 54.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 1.018 HD21 HD21 ' A' ' 459' ' ' LEU . 4.5 mp -71.37 -27.99 63.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.547 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.21 28.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.385 -0.822 . . . . 0.0 109.513 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.33 -27.36 68.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.555 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.434 ' CG2' ' HD3' ' A' ' 447' ' ' LYS . 33.2 mm -64.11 159.55 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.496 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 470' ' ' ILE . 87.5 tt0 -93.5 142.44 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.364 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 84.13 0.53 89.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.87 HD22 ' HD3' ' A' ' 477' ' ' LYS . 0.3 OUTLIER -100.77 129.47 46.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -1.193 . . . . 0.0 109.377 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.831 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -108.38 168.47 9.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.25 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.2 -47.36 44.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -0.94 . . . . 0.0 109.01 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.87 ' HD3' HD22 ' A' ' 473' ' ' LEU . 28.2 tttt -61.24 -38.95 88.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.067 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.931 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -58.16 -46.47 85.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.109 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 480' ' ' ALA . . . -62.31 -77.67 0.2 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -40.95 -43.48 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 109.568 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 439' ' ' GLY . 2.4 tp -62.59 -68.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.361 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.954 HD11 HD22 ' A' ' 467' ' ' LEU . 78.2 mt -57.83 -29.85 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.172 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.537 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 85.2 mtp -72.8 -29.62 63.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -69.87 -35.19 74.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 109.097 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.789 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.42 -41.7 55.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.692 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 26.6 mtt180 -68.26 -42.77 79.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 483' ' ' MET . 92.6 m-20 -60.45 -35.64 76.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.481 -0.762 . . . . 0.0 109.658 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 484' ' ' ALA . 76.2 mt -86.96 -36.14 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 110.053 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.613 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.1 m -82.01 -33.46 30.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.648 ' CH2' ' NE ' ' A' ' 486' ' ' ARG . 44.2 m0 -95.22 -84.94 0.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.545 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 24.7 m-85 -43.45 -38.24 2.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.373 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -55.27 -31.49 56.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 490' ' ' TRP . 91.6 m-20 -59.25 -34.91 72.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.144 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -34.07 71.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.477 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 58.27 39.77 25.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -1.12 . . . . 0.0 109.564 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 449' ' ' ALA . 50.8 m-20 -87.41 142.68 27.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -98.03 139.69 21.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.441 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.843 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 54.5 Cg_endo -74.48 157.02 45.28 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.661 2.24 . . . . 0.0 111.942 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.51 152.41 36.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -49.83 -35.12 21.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -59.05 -42.66 90.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 108.923 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.985 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.2 OUTLIER -77.38 -44.25 29.98 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.615 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.7 tp -58.8 -47.37 85.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 57.7 m-80 -81.59 1.34 34.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.532 -0.73 . . . . 0.0 109.86 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 440' ' ' VAL . 21.5 tp -62.73 123.4 18.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.285 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -58.38 -26.1 62.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.158 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.499 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -86.13 -12.62 70.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.985 HG11 ' CD1' ' A' ' 434' ' ' LEU . 70.5 t -118.59 118.99 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -1.164 . . . . 0.0 109.863 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . 0.514 ' OD1' ' CB ' ' A' ' 444' ' ' LEU . 23.5 p-10 -83.09 -174.48 5.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 108.95 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 19.4 ttp85 -61.75 -45.59 93.27 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 108.985 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.3 -57.38 10.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 110.136 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.833 HD22 HG22 ' A' ' 440' ' ' VAL . 6.5 tt -52.28 -32.51 37.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.989 -1.069 . . . . 0.0 108.767 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -56.8 -40.89 76.75 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.07 -36.56 48.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 471' ' ' GLU . 90.5 mttt -64.81 -37.4 87.49 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.908 HD23 ' HG ' ' A' ' 434' ' ' LEU . 16.1 tp -80.49 -39.9 27.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.34 -35.04 77.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.75 64.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.568 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -93.03 17.1 11.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.37 -9.09 59.37 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.709 HG13 ' C ' ' A' ' 458' ' ' ASP . 16.7 t -94.91 64.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -1.13 . . . . 0.0 109.192 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 431' ' ' ALA . 59.2 m -86.5 -7.8 58.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.207 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.405 ' OG1' ' CG ' ' A' ' 458' ' ' ASP . 1.1 p -111.75 142.03 44.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.767 -1.208 . . . . 0.0 109.833 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.792 HD11 ' CB ' ' A' ' 485' ' ' ALA . 37.2 tp -50.33 -39.33 45.69 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.266 -0.896 . . . . 0.0 109.08 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.442 ' HG3' ' SG ' ' A' ' 489' ' ' CYS . 94.9 mt-10 -61.23 -41.6 97.16 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.268 -0.895 . . . . 0.0 108.607 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.709 ' C ' HG13 ' A' ' 453' ' ' VAL . 87.1 m-20 -59.04 -38.21 78.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.992 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 459' ' ' LEU . 3.4 tm? -72.77 -40.27 66.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.422 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.14 -24.66 64.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.235 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -86.14 -7.43 58.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.84 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.2 mm-40 -82.39 160.55 22.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.904 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -114.82 165.73 12.1 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.668 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.8 mt -53.31 -38.2 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 109.883 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -71.55 -35.46 70.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.925 . . . . 0.0 109.859 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.08 -44.7 88.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.454 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 482' ' ' ILE . 32.2 mt -79.87 -13.05 59.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.07 -19.31 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.67 5.26 18.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 471' ' ' GLU . 39.2 mm -93.46 159.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.522 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.507 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 86.1 tt0 -98.6 138.22 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.822 . . . . 0.0 109.294 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 82.53 9.75 84.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 478' ' ' ALA . 15.5 tp -111.85 125.95 54.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -101.02 169.86 8.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.692 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.91 -41.41 99.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.32 -46.05 43.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.989 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.673 ' HG2' HD13 ' A' ' 481' ' ' LEU . 53.8 tttp -59.54 -40.6 87.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 109.057 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.03 -41.49 87.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 109.065 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -62.73 -32.69 84.49 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -77.51 -50.66 12.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.381 -1.07 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.673 HD13 ' HG2' ' A' ' 477' ' ' LYS . 10.4 mp -55.81 -51.31 67.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.008 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.744 HG22 ' NE ' ' A' ' 486' ' ' ARG . 68.7 mt -61.68 -36.25 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 108.858 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.521 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 22.6 mtm -75.28 -32.46 61.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.13 -44.9 87.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 108.884 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.792 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -72.01 -38.15 69.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.744 ' NE ' HG22 ' A' ' 482' ' ' ILE . 28.1 mtt180 -64.25 -44.56 91.4 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 483' ' ' MET . 88.1 m-20 -63.15 -33.26 75.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.478 ' O ' ' HA2' ' A' ' 492' ' ' GLY . 80.6 mt -85.66 -37.71 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 109.674 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 457' ' ' GLU . 1.3 m -80.57 -29.13 37.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.477 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 47.4 m0 -97.74 -85.25 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.41 -39.63 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 74.69 26.98 66.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.59 134.94 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -1.19 . . . . 0.0 109.477 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.1 -34.76 79.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.476 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -55.18 -38.03 67.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -1.178 . . . . 0.0 109.574 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 84.1 m-20 57.78 54.17 6.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -63.04 151.0 87.18 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.767 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 52.2 Cg_endo -72.38 142.95 38.01 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.735 2.29 . . . . 0.0 111.948 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -76.44 156.65 32.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 88.6 m-20 -50.18 -36.56 30.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.73 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -62.56 -39.34 93.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.039 -1.038 . . . . 0.0 109.132 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.812 HD13 HD23 ' A' ' 448' ' ' LEU . 26.8 mt -79.43 -36.94 38.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 0.0 109.088 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 445' ' ' ALA . 7.6 tp -70.16 -40.29 74.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.744 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 59.9 m-80 -87.62 0.76 55.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.545 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 440' ' ' VAL . 17.6 tp -64.14 125.2 23.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.431 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.92 -23.16 63.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -90.43 -16.94 54.4 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 444' ' ' LEU . 74.3 t -117.95 112.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -1.147 . . . . 0.0 109.344 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -76.24 173.74 11.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.326 -0.859 . . . . 0.0 108.805 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -56.22 -43.98 79.11 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.148 -0.97 . . . . 0.0 108.629 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.03 -48.29 66.07 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.018 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 444' ' ' LEU . 8.2 tt -60.29 -27.17 67.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.925 -1.11 . . . . 0.0 109.215 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.767 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.14 -30.41 71.34 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -73.72 -48.7 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 108.884 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.548 ' HD3' HG23 ' A' ' 470' ' ' ILE . 50.5 tttp -62.42 -29.68 70.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.855 . . . . 0.0 109.151 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.924 HD11 HD23 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -84.34 -41.5 16.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -70.73 -34.02 71.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.449 -0.782 . . . . 0.0 109.495 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.2 -11.21 58.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.625 ' HD2' HD11 ' A' ' 470' ' ' ILE . 82.7 mtt-85 -99.97 16.1 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 99.1 -25.88 26.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 458' ' ' ASP . 1.1 t -77.89 72.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -1.215 . . . . 0.0 108.815 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 431' ' ' ALA . 33.9 m -82.84 -4.98 58.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.079 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 431' ' ' ALA . 3.2 p -140.25 160.63 39.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.889 -1.132 . . . . 0.0 109.976 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.833 HD11 ' CB ' ' A' ' 485' ' ' ALA . 12.8 tp -58.98 -39.15 80.91 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.512 -0.742 . . . . 0.0 109.01 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.476 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 89.8 mt-10 -56.92 -38.81 73.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.378 -0.826 . . . . 0.0 109.003 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.559 ' C ' HG13 ' A' ' 453' ' ' VAL . 77.0 m-20 -65.46 -33.07 75.07 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.924 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -71.8 -36.59 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.124 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.636 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -62.71 -23.47 67.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.158 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -85.23 -11.34 55.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 467' ' ' LEU . 39.8 mm-40 -79.47 161.75 25.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.932 . . . . 0.0 109.776 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.76 158.58 18.35 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 478' ' ' ALA . 76.8 mt -46.25 -36.1 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 109.876 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -70.53 -38.3 74.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.05 -43.01 83.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 459' ' ' LEU . 10.9 mp -76.4 -24.92 54.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.4 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.11 35.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -65.65 -26.25 67.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 451' ' ' ARG . 32.3 mm -66.69 156.73 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -96.04 136.67 36.18 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.77 1.46 73.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.766 HD13 ' N ' ' A' ' 474' ' ' THR . 0.3 OUTLIER -104.79 126.97 52.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -1.196 . . . . 0.0 109.355 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -106.56 170.24 8.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.327 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.39 -46.19 89.74 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.91 -43.43 88.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.479 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.725 ' HD3' HD22 ' A' ' 473' ' ' LEU . 22.7 tttt -61.37 -45.79 92.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 473' ' ' LEU . . . -59.32 -39.73 84.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.797 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.647 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -58.25 -41.81 95.09 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -81.26 -52.83 6.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -1.173 . . . . 0.0 109.639 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 439' ' ' GLY . 1.0 OUTLIER -51.32 -55.48 18.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.277 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.727 ' HA ' HD11 ' A' ' 459' ' ' LEU . 59.8 mt -65.74 -30.85 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 44.2 mtp -79.45 -29.91 41.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -68.7 -43.78 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 108.971 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -71.66 -40.43 69.64 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.396 -0.815 . . . . 0.0 108.948 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.666 ' HD2' HG22 ' A' ' 482' ' ' ILE . 88.3 mtt180 -65.33 -41.96 93.4 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.8 m-20 -60.0 -34.75 73.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.284 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 75.7 mt -86.89 -39.02 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.092 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 457' ' ' GLU . 14.7 m -81.09 -35.9 31.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.489 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 45.7 m0 -92.7 -85.1 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.344 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -48.85 -39.5 25.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 109.285 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.55 143.33 30.21 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.9 138.52 54.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.698 ' O ' ' HB3' ' A' ' 495' ' ' ALA . 73.3 mm-40 -63.48 -33.35 75.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -55.96 -37.17 68.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -1.181 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.978 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 24.6 m120 -54.25 -36.97 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.668 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 454' ' ' CYS . 14.2 ttpp -48.22 136.88 11.61 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 454' ' ' CYS . 51.8 Cg_endo -71.76 141.3 37.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.893 2.396 . . . . 0.0 112.301 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -73.83 157.26 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.825 . . . . 0.0 109.798 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.536 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 93.2 m-20 -55.7 -31.5 62.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.461 -0.775 . . . . 0.0 110.16 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -57.39 -36.5 71.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.027 -1.046 . . . . 0.0 109.186 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.78 ' CD2' HD22 ' A' ' 448' ' ' LEU . 6.7 tp -79.82 -48.94 12.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.451 -0.781 . . . . 0.0 109.366 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 442' ' ' ARG . 4.6 mt -57.76 -42.29 83.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.762 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 57.0 m-80 -84.35 -0.13 51.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.8 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.48 HD22 ' CD1' ' A' ' 456' ' ' LEU . 9.2 tp -69.85 126.85 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.105 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.02 -23.72 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.002 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -84.9 -21.42 55.7 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.733 HG13 HD22 ' A' ' 444' ' ' LEU . 59.9 t -120.88 117.32 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -1.205 . . . . 0.0 109.67 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.21 174.82 10.29 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.333 -0.854 . . . . 0.0 108.812 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.784 ' HA ' HD23 ' A' ' 435' ' ' LEU . 42.1 ttt-85 -57.8 -43.05 85.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.953 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -67.49 -46.53 72.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.573 -0.705 . . . . 0.0 109.946 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.733 HD22 HG13 ' A' ' 440' ' ' VAL . 3.3 tt -57.08 -34.81 68.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 0.0 109.143 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.569 ' HA ' HD23 ' A' ' 434' ' ' LEU . . . -55.89 -31.72 63.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -75.19 -46.02 36.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 108.94 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.673 ' CE ' HG23 ' A' ' 470' ' ' ILE . 37.6 tttp -59.28 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.101 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 1.002 HD11 HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -85.29 -40.98 15.96 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.337 -0.852 . . . . 0.0 109.03 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.978 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -66.59 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.54 -10.51 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.771 ' CD ' HD11 ' A' ' 470' ' ' ILE . 19.6 mtp180 -102.15 15.7 28.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.697 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.42 -21.34 32.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.822 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.5 t -91.77 103.1 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -1.15 . . . . 0.0 108.963 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.603 ' CB ' ' HA ' ' A' ' 430' ' ' PRO . 0.5 OUTLIER -117.91 -32.05 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 109.683 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 431' ' ' ALA . 1.2 p -94.92 144.83 25.35 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.13 -0.981 . . . . 0.0 109.741 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.825 HD11 ' CB ' ' A' ' 485' ' ' ALA . 23.3 tp -46.08 -40.4 10.76 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.374 -0.829 . . . . 0.0 109.114 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.482 ' HG2' ' SG ' ' A' ' 489' ' ' CYS . 96.0 mt-10 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 109.139 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.641 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.0 m-20 -55.26 -39.98 70.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.14 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.034 HD11 HD21 ' A' ' 467' ' ' LEU . 23.1 tp -71.27 -39.25 71.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.661 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -55.85 -28.96 58.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.451 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.4 tt0 -85.34 -8.42 58.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.841 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 55.6 mm-40 -82.38 161.93 22.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.02 156.69 15.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 1.016 HG23 ' HB3' ' A' ' 478' ' ' ALA . 93.5 mt -48.58 -38.56 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -1.086 . . . . 0.0 109.717 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.25 -38.39 87.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -64.21 -49.21 72.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.482 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 1.034 HD21 HD11 ' A' ' 459' ' ' LEU . 10.3 mp -77.68 -23.14 49.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 464' ' ' ILE . . . -50.97 -31.88 19.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 109.631 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -62.42 -27.19 68.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.771 HD11 ' CD ' ' A' ' 451' ' ' ARG . 39.1 mm -60.65 156.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.497 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.424 ' H ' ' HE2' ' A' ' 447' ' ' LYS . 84.7 tt0 -94.85 138.27 32.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.318 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.36 2.49 73.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.598 HD12 ' HD3' ' A' ' 477' ' ' LYS . 15.0 tp -110.66 129.06 55.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.381 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -102.89 172.12 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.26 -41.05 97.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.0 109.302 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.18 -44.24 63.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.185 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.598 ' HD3' HD12 ' A' ' 473' ' ' LEU . 33.8 tttt -61.34 -41.91 97.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.253 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 1.016 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.06 -35.72 81.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.86 -36.43 93.29 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.73 -53.15 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.523 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 439' ' ' GLY . 4.1 mm? -50.24 -58.92 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.254 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.64 ' CG1' HD22 ' A' ' 467' ' ' LEU . 73.1 mt -62.06 -34.03 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.775 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 42.7 mtp -76.78 -29.65 56.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -65.23 -44.39 88.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.129 -0.982 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.825 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -73.25 -43.05 61.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 108.936 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.559 ' NE ' HG22 ' A' ' 482' ' ' ILE . 91.1 mtt180 -60.16 -41.1 92.09 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.0 m-20 -66.17 -29.72 70.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.505 -0.747 . . . . 0.0 109.278 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 484' ' ' ALA . 97.4 mt -79.81 -31.13 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.868 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 457' ' ' GLU . 0.6 OUTLIER -96.77 -20.93 17.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.468 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 46.9 m0 -103.11 -90.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -49.94 -43.53 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.561 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -45.24 102.73 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -91.75 114.83 27.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -1.098 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.18 152.97 23.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.682 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.485 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 55.6 45.24 25.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 454' ' ' CYS . 0.9 OUTLIER 57.49 39.38 27.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.49 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -82.44 150.31 63.26 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.613 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 49.8 Cg_endo -70.92 147.26 55.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.63 2.22 . . . . 0.0 111.805 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 455' ' ' THR . . . -77.38 155.64 31.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.499 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 90.2 m-20 -50.57 -36.17 33.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.18 -39.62 83.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.077 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.121 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.6 OUTLIER -77.75 -42.63 33.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.34 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.581 HD11 ' HG2' ' A' ' 430' ' ' PRO . 0.8 OUTLIER -65.62 -40.87 93.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.653 -0.654 . . . . 0.0 109.943 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 67.0 m-80 -84.54 -0.77 54.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.777 HD22 ' CD1' ' A' ' 456' ' ' LEU . 11.5 tp -63.41 129.54 40.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -59.45 -28.72 67.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.832 . . . . 0.0 110.112 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.524 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.25 2.47 86.71 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.121 HG11 ' CD1' ' A' ' 434' ' ' LEU . 66.6 t -137.91 119.43 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -1.113 . . . . 0.0 110.043 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -80.96 172.72 13.4 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -56.05 -41.81 75.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.152 -0.968 . . . . 0.0 108.772 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -71.92 -45.48 61.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.525 -0.734 . . . . 0.0 110.137 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 444' ' ' LEU . 6.6 tt -59.77 -25.02 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.975 -1.078 . . . . 0.0 109.36 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.613 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -65.01 -25.77 67.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.177 -0.952 . . . . 0.0 109.119 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -77.95 -48.26 16.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.492 ' HD3' ' CG2' ' A' ' 470' ' ' ILE . 36.6 tttp -58.42 -34.97 71.38 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 1.018 HD11 HD13 ' A' ' 459' ' ' LEU . 0.8 OUTLIER -80.19 -40.89 26.31 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.658 ' HB1' ' SG ' ' A' ' 454' ' ' CYS . . . -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -0.769 . . . . 0.0 109.041 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.01 -10.12 59.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.234 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.93 ' HD2' HD11 ' A' ' 470' ' ' ILE . 2.9 ttt85 -97.76 14.73 25.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.687 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.84 -17.51 56.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.644 ' HA ' ' HB3' ' A' ' 458' ' ' ASP . 0.3 OUTLIER -92.89 76.05 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.423 -1.045 . . . . 0.0 109.031 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.658 ' SG ' ' HB1' ' A' ' 449' ' ' ALA . 11.1 m -85.49 -35.18 21.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.81 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.673 HG22 ' HB2' ' A' ' 431' ' ' ALA . 2.1 p -98.47 150.31 21.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.046 -1.034 . . . . 0.0 110.067 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.777 ' CD1' HD22 ' A' ' 437' ' ' LEU . 11.3 tp -53.79 -38.89 64.95 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.505 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 88.1 mt-10 -58.68 -40.19 82.87 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.644 ' HB3' ' HA ' ' A' ' 453' ' ' VAL . 92.1 m-20 -55.8 -36.17 67.11 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.545 -0.722 . . . . 0.0 109.14 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.018 HD13 HD11 ' A' ' 448' ' ' LEU . 15.6 tp -72.07 -38.36 69.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.837 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -56.39 -20.83 21.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -0.974 . . . . 0.0 109.446 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -94.63 -10.4 32.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 50.9 mm-40 -82.44 160.68 22.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.072 . . . . 0.0 109.692 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.15 157.86 15.16 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.697 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.4 mt -51.0 -37.06 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.057 . . . . 0.0 109.624 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.43 -37.37 74.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.678 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -68.46 -45.34 72.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.561 ' CD1' HD11 ' A' ' 482' ' ' ILE . 17.1 mt -71.8 -21.54 61.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.403 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -47.89 -32.97 6.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.93 HD11 ' HD2' ' A' ' 451' ' ' ARG . 26.1 mm -62.86 164.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.419 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.1 tt0 -111.5 139.86 46.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.92 2.65 71.48 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.536 HD21 HD22 ' A' ' 481' ' ' LEU . 11.1 mt -111.46 142.54 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -1.096 . . . . 0.0 109.447 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.448 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -110.91 166.75 10.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.684 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 87.5 m-20 -60.98 -42.07 97.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.521 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -74.96 -45.05 44.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HG2' HD13 ' A' ' 481' ' ' LEU . 20.8 tttt -61.08 -40.59 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.286 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -64.79 -37.06 86.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.241 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.62 -30.75 78.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -79.69 -54.64 5.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.35 -1.088 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.559 HD13 ' HG2' ' A' ' 477' ' ' LYS . 8.0 mp -49.96 -52.7 31.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.322 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.814 HG22 ' NE ' ' A' ' 486' ' ' ARG . 73.5 mt -63.31 -37.94 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.243 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.543 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 26.1 mtm -70.54 -33.46 71.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 108.986 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -64.95 -38.97 92.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 108.631 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 456' ' ' LEU . . . -77.27 -37.05 53.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.814 ' NE ' HG22 ' A' ' 482' ' ' ILE . 68.0 mtt180 -65.6 -42.56 91.49 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 483' ' ' MET . 80.6 m-20 -62.36 -40.26 95.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.533 -0.73 . . . . 0.0 109.475 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 492' ' ' GLY . 77.6 mt -79.71 -39.72 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.505 ' SG ' ' CG ' ' A' ' 457' ' ' GLU . 11.3 m -75.99 -33.7 59.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.689 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.458 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 43.0 m0 -96.17 -83.22 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.561 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 57.3 m-85 -47.27 -36.19 8.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.869 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 491' ' ' PHE . . . -49.87 -176.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.31 6.65 25.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -1.127 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 489' ' ' CYS . 77.4 tt0 -51.82 -33.68 36.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.468 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.479 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.31 -35.76 72.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -1.11 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -108.71 128.94 55.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.1 OUTLIER -134.89 153.56 78.74 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.791 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.0 Cg_endo -72.08 138.83 31.59 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.577 2.185 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.95 150.04 39.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.587 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -52.98 -31.67 41.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.246 -0.908 . . . . 0.0 109.709 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -59.76 -42.78 94.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.975 -1.078 . . . . 0.0 108.896 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.843 HD22 HD22 ' A' ' 448' ' ' LEU . 0.6 OUTLIER -80.68 -50.89 9.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.601 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.2 tp -47.5 -45.04 26.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 69.4 m-80 -84.05 3.05 36.28 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.6 -0.687 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 13.9 tp -68.24 120.07 13.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 109.767 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.22 -21.89 26.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -0.827 . . . . 0.0 109.951 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.653 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -89.43 -15.96 57.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.756 HG11 ' CD2' ' A' ' 434' ' ' LEU . 92.2 t -118.73 119.14 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.175 -1.191 . . . . 0.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -80.85 169.91 16.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.302 -0.874 . . . . 0.0 108.9 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 36.7 ttm180 -53.71 -41.43 66.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.109 -0.994 . . . . 0.0 108.464 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.34 -55.26 19.23 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.639 -0.663 . . . . 0.0 109.847 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.691 HD22 HG13 ' A' ' 440' ' ' VAL . 5.2 tt -53.27 -32.78 50.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 108.774 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.791 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -54.87 -39.5 68.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -76.16 -34.42 59.37 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 30.5 mttm -69.98 -32.59 70.87 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 459' ' ' LEU . 6.1 tt -88.47 -38.05 15.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -70.44 -30.75 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.436 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.644 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.807 ' HD3' HD11 ' A' ' 470' ' ' ILE . 41.4 mtm105 -91.53 17.87 8.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 109.557 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 87.38 -8.66 76.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.755 ' O ' HD23 ' A' ' 448' ' ' LEU . 1.6 t -90.65 72.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -1.029 . . . . 0.0 108.856 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 66.9 m -83.79 -13.39 53.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 110.487 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -120.58 151.04 39.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.993 -1.067 . . . . 0.0 110.145 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.885 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.4 tp -54.17 -38.57 65.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.57 -44.53 96.07 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.686 ' C ' HG13 ' A' ' 453' ' ' VAL . 92.2 m-20 -57.6 -33.45 68.21 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 448' ' ' LEU . 3.4 tm? -74.59 -38.37 62.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.076 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.625 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -63.06 -22.61 66.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.46 -9.44 58.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 51.3 mm-40 -81.0 161.39 24.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 0.0 109.725 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -122.21 168.35 14.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 475' ' ' ASP . 97.1 mt -54.34 -36.56 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -1.164 . . . . 0.0 109.76 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.55 -36.79 73.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.353 -0.842 . . . . 0.0 109.617 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.82 -41.5 91.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 482' ' ' ILE . 3.7 mp -82.06 -12.05 58.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.346 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.39 -32.91 51.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.36 -29.67 70.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.807 HD11 ' HD3' ' A' ' 451' ' ' ARG . 25.9 mm -63.5 164.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.469 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -113.51 139.74 48.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.17 5.16 65.99 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 473' ' ' LEU . 13.4 mt -110.56 143.93 40.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -1.155 . . . . 0.0 109.367 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.439 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -122.08 165.84 15.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.658 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.408 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.1 m-20 -56.17 -44.35 79.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -72.86 -47.81 42.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 481' ' ' LEU . 15.0 tttp -62.96 -39.65 95.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.61 78.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.029 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.591 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -64.18 -30.06 76.71 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.3 -63.65 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -1.052 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.653 HD21 ' O ' ' A' ' 439' ' ' GLY . 6.5 mp -44.61 -53.27 7.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 108.909 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 1.068 HD11 HD22 ' A' ' 467' ' ' LEU . 54.6 mt -60.99 -35.62 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.82 . . . . 0.0 109.139 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.591 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 24.2 mtm -75.17 -27.75 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -0.839 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.58 -42.14 87.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.086 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.885 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.22 -34.62 61.48 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.776 ' NE ' HG22 ' A' ' 482' ' ' ILE . 47.2 mtt180 -69.01 -44.05 73.55 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.3 m-20 -62.72 -34.78 77.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.51 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 72.2 mt -85.71 -39.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.902 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.883 ' SG ' HD23 ' A' ' 456' ' ' LEU . 4.0 m -77.61 -32.71 53.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.495 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 50.9 m0 -94.99 -83.88 0.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.604 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -55.42 -39.07 69.79 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.349 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -79.7 142.9 25.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -90.66 115.59 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -1.146 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -56.17 142.59 36.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.541 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.447 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -58.28 -34.66 70.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -1.134 . . . . 0.0 109.504 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.19 131.35 42.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -137.77 148.54 61.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.482 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.819 ' HG2' HD11 ' A' ' 435' ' ' LEU . 48.3 Cg_endo -70.14 137.84 35.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.673 2.249 . . . . 0.0 111.941 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -77.16 156.49 31.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB3' ' ND2' ' A' ' 436' ' ' ASN . 91.0 m-20 -51.9 -35.16 44.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 109.751 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.28 -39.66 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.06 -1.025 . . . . 0.0 109.287 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.066 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.4 OUTLIER -77.6 -41.84 37.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.819 HD11 ' HG2' ' A' ' 430' ' ' PRO . 5.6 mt -68.42 -37.32 80.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 432' ' ' ASP . 72.5 m-80 -84.44 0.41 49.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 0.0 110.027 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 440' ' ' VAL . 9.7 tp -66.55 125.04 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.323 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.27 -26.49 51.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.13 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.731 ' C ' HD21 ' A' ' 481' ' ' LEU . . . -88.16 -12.19 66.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.066 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -118.36 125.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.937 -1.331 . . . . 0.0 109.95 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 11.9 p30 -92.35 -177.21 4.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.914 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 24.7 ttt180 -59.68 -42.78 93.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 108.792 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.61 -60.74 3.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.798 . . . . 0.0 109.716 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.89 HD22 HG22 ' A' ' 440' ' ' VAL . 5.5 tt -50.73 -31.57 16.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.065 -1.022 . . . . 0.0 108.498 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . -54.62 -38.48 66.86 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -79.16 -37.9 37.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 470' ' ' ILE . 24.8 mttt -66.35 -31.74 72.71 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.818 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.8 tm? -84.7 -46.78 11.12 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.564 -0.71 . . . . 0.0 109.138 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 448' ' ' LEU . . . -65.89 -30.52 71.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -67.68 -7.34 26.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 109.392 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -100.23 16.75 23.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.04 -6.3 79.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.599 ' O ' ' CD1' ' A' ' 448' ' ' LEU . 0.6 OUTLIER -90.62 66.13 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.121 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 60.4 m -70.72 -15.31 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.978 . . . . 0.0 110.584 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 458' ' ' ASP . 1.6 p -121.43 149.06 43.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.77 -1.207 . . . . 0.0 109.999 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.77 HD23 ' SG ' ' A' ' 489' ' ' CYS . 6.5 tp -55.91 -38.72 70.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.436 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 93.2 mt-10 -58.11 -39.1 77.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.557 ' HB3' HG13 ' A' ' 453' ' ' VAL . 96.2 m-20 -59.54 -32.45 70.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 467' ' ' LEU . 26.0 tp -72.76 -32.29 65.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.298 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.611 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -60.18 -23.4 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 108.971 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.73 -7.7 51.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 109.628 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.507 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 46.6 mm-40 -85.93 160.74 19.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.676 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -118.68 166.27 12.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 478' ' ' ALA . 98.2 mt -55.24 -35.93 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.177 . . . . 0.0 109.617 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.82 -34.82 67.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -64.68 -41.45 96.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.349 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 459' ' ' LEU . 3.8 mp -84.06 -10.24 57.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.835 . . . . 0.0 109.448 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.93 62.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.3 -28.79 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 447' ' ' LYS . 26.6 mm -59.93 163.01 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.8 tt0 -109.91 135.68 50.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.47 -3.4 71.91 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.975 HD21 ' HB2' ' A' ' 478' ' ' ALA . 7.9 tt -104.62 136.02 44.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.121 . . . . 0.0 109.466 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.471 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -110.86 166.79 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 464' ' ' ILE . 89.9 m-20 -57.83 -42.06 83.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.64 -43.77 75.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -61.64 -44.06 97.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.975 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -65.94 -38.14 87.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.281 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -57.69 -39.0 90.51 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.35 -47.19 14.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -1.15 . . . . 0.0 109.637 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.81 HD22 HG23 ' A' ' 440' ' ' VAL . 6.2 mt -58.29 -53.64 55.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.24 -0.912 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 467' ' ' LEU . 74.6 mt -63.94 -31.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 108.75 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 5.2 mtt -76.46 -34.25 58.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 488' ' ' ILE . . . -68.88 -36.29 77.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.714 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.43 -41.38 60.96 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.611 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.2 mtt180 -67.78 -42.98 80.82 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 492' ' ' GLY . 88.4 m-20 -62.91 -36.31 82.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.549 -0.72 . . . . 0.0 109.631 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 484' ' ' ALA . 95.8 mt -83.77 -43.94 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.745 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.77 ' SG ' HD23 ' A' ' 456' ' ' LEU . 30.3 m -70.45 -35.45 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.653 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -93.6 -81.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 62.5 m-85 -56.69 -37.74 71.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.791 . . . . 0.0 109.264 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -75.97 -178.8 44.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 493' ' ' ASP . 52.7 p30 -150.74 176.3 11.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -1.157 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -105.17 152.28 23.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 109.442 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.488 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -57.13 -36.43 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -1.096 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.438 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 87.6 m-20 -105.63 137.97 42.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 3.6 mttp -122.93 146.1 47.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.636 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.36 142.48 33.5 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.631 2.221 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.4 154.93 34.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.239 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.561 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.1 m-20 -49.85 -36.51 27.14 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -60.25 -44.05 95.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 108.871 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.048 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -77.34 -44.73 28.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.447 -0.783 . . . . 0.0 108.945 179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.63 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 9.7 tp -57.17 -45.81 83.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.583 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 64.3 m-80 -82.99 1.06 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 109.785 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 456' ' ' LEU . 0.2 OUTLIER -59.97 121.7 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.83 -26.54 62.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.95 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.798 ' O ' HD21 ' A' ' 481' ' ' LEU . . . -87.26 -11.79 68.79 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.048 HG11 ' CD1' ' A' ' 434' ' ' LEU . 71.3 t -117.84 113.95 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 109.524 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 444' ' ' LEU . 1.1 p-10 -77.32 179.18 6.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 108.96 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 43.7 ttt180 -58.73 -45.65 89.16 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.149 -0.969 . . . . 0.0 108.725 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -65.56 -52.38 52.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.556 -0.715 . . . . 0.0 109.857 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.775 HD22 HG22 ' A' ' 440' ' ' VAL . 5.9 tt -54.87 -33.61 62.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.979 -1.076 . . . . 0.0 108.782 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -53.58 -38.29 63.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.94 -37.43 55.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 444' ' ' LEU . 51.5 mttm -66.35 -32.94 74.65 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.78 HD12 ' HG ' ' A' ' 434' ' ' LEU . 1.7 tm? -84.73 -41.04 16.6 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.74 69.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.381 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.69 62.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.988 ' HD2' HD11 ' A' ' 470' ' ' ILE . 31.9 mtp85 -91.86 18.08 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.39 -8.52 64.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 458' ' ' ASP . 0.4 OUTLIER -86.87 69.57 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.431 -1.041 . . . . 0.0 109.064 179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 431' ' ' ALA . 23.9 m -76.8 -17.02 59.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 110.348 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 p -116.84 147.96 41.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.905 -1.122 . . . . 0.0 109.887 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.816 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 4.1 tp -54.16 -37.4 64.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.468 ' HA ' ' SG ' ' A' ' 489' ' ' CYS . 34.5 tt0 -59.92 -43.36 94.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.585 ' HB3' HG13 ' A' ' 453' ' ' VAL . 95.1 m-20 -52.77 -36.67 58.41 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 467' ' ' LEU . 20.4 tp -70.4 -34.32 72.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.247 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.69 -20.33 55.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 0.0 109.082 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 81.7 tt0 -93.33 -10.05 36.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 459' ' ' LEU . 49.3 mm-40 -82.92 159.89 22.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.078 -1.014 . . . . 0.0 109.423 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -116.92 156.23 15.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.996 HG23 ' HB3' ' A' ' 478' ' ' ALA . 81.6 mt -50.46 -39.01 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.633 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -69.89 -34.16 73.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -68.4 -41.59 80.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 482' ' ' ILE . 30.7 mt -84.31 -12.66 54.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.86 51.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.426 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.56 -27.64 68.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.988 HD11 ' HD2' ' A' ' 451' ' ' ARG . 39.9 mm -57.23 158.91 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.0 tt0 -101.81 134.37 45.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.867 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.46 -0.95 75.32 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 478' ' ' ALA . 8.8 tt -105.36 134.82 47.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 473' ' ' LEU . 0.0 OUTLIER -114.37 168.86 9.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.393 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -55.44 -40.69 71.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.21 -43.11 78.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 473' ' ' LEU . 16.1 tttt -63.04 -44.49 95.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 1.039 ' HB2' HD21 ' A' ' 473' ' ' LEU . . . -63.29 -35.13 79.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.258 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -61.93 -40.1 98.42 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.55 -56.95 3.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -1.199 . . . . 0.0 109.927 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 439' ' ' GLY . 10.9 mp -48.84 -55.76 10.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.39 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.673 HD11 HD12 ' A' ' 467' ' ' LEU . 60.3 mt -63.44 -36.39 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 109.409 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 45.9 mtp -73.74 -31.3 63.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.44 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -67.64 -36.95 81.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.061 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.816 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -76.26 -38.56 56.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.574 ' HG2' ' HB1' ' A' ' 460' ' ' ALA . 97.8 mtt180 -68.53 -44.24 75.01 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 483' ' ' MET . 87.7 m-20 -60.73 -38.58 85.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 484' ' ' ALA . 80.4 mt -80.62 -38.62 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.383 -0.823 . . . . 0.0 109.984 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 456' ' ' LEU . 7.2 m -80.01 -34.23 38.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.2 m0 -93.24 -84.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -50.74 -39.9 53.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.855 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . 56.7 -134.38 51.67 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 22.6 t70 48.16 36.32 6.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.184 -1.186 . . . . 0.0 109.38 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 495' ' ' ALA . 84.3 tt0 -62.63 -34.23 76.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.05 -36.76 70.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -107.24 135.09 49.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.37 141.8 31.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.595 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.781 ' HG3' ' HB1' ' A' ' 445' ' ' ALA . 52.6 Cg_endo -71.48 143.93 43.97 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.691 2.26 . . . . 0.0 111.669 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -74.23 156.38 37.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 89.7 m-20 -51.91 -34.5 41.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.97 -42.34 98.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.046 -1.034 . . . . 0.0 109.08 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 1.024 ' CD1' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -78.27 -44.02 26.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 109.131 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.489 HD13 ' HG2' ' A' ' 430' ' ' PRO . 8.5 tp -59.21 -49.31 78.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.609 -0.682 . . . . 0.0 109.714 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 67.7 m-80 -76.41 1.47 16.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 456' ' ' LEU . 6.9 tp -68.57 116.22 8.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.15 -0.969 . . . . 0.0 108.923 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -61.37 -24.24 66.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.387 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 481' ' ' LEU . . . -79.94 -26.58 55.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.024 HG11 ' CD1' ' A' ' 434' ' ' LEU . 53.4 t -102.2 121.91 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -1.119 . . . . 0.0 109.934 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . 0.477 ' HB2' HD13 ' A' ' 444' ' ' LEU . 78.0 m-20 -81.4 176.18 9.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.333 -0.854 . . . . 0.0 108.877 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 445' ' ' ALA . 30.9 ttm180 -57.78 -43.14 85.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.13 -0.981 . . . . 0.0 108.662 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 447' ' ' LYS . 93.5 m-20 -60.96 -53.16 60.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.666 -0.646 . . . . 0.0 109.561 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 444' ' ' LEU . 7.4 mp -57.13 -31.53 65.41 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.781 ' HB1' ' HG3' ' A' ' 430' ' ' PRO . . . -57.31 -41.72 80.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.77 -39.85 30.03 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 470' ' ' ILE . 56.1 mttp -63.97 -36.66 84.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.472 -0.768 . . . . 0.0 108.929 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 459' ' ' LEU . 0.6 OUTLIER -80.01 -44.81 19.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.158 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 453' ' ' VAL . . . -66.36 -35.34 80.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.66 -18.62 62.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 451' ' ' ARG . 55.3 ttt85 -90.16 17.27 7.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 0.0 109.503 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 90.8 -7.27 81.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 459' ' ' LEU . 0.2 OUTLIER -91.03 71.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.297 -1.119 . . . . 0.0 109.163 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 431' ' ' ALA . 29.2 m -82.2 -8.66 59.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.471 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 1.3 p -130.99 146.56 52.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.076 -1.015 . . . . 0.0 109.598 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.83 HD23 ' SG ' ' A' ' 489' ' ' CYS . 4.7 tp -51.63 -38.86 56.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.361 -0.837 . . . . 0.0 109.052 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.536 ' OE2' ' HB1' ' A' ' 495' ' ' ALA . 93.3 mt-10 -58.52 -39.72 80.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 108.847 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.541 ' C ' HG13 ' A' ' 453' ' ' VAL . 83.7 m-20 -60.57 -33.34 72.56 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 448' ' ' LEU . 64.7 tp -71.1 -31.73 68.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 108.913 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 486' ' ' ARG . . . -61.3 -20.69 63.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.42 -0.8 . . . . 0.0 109.06 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.5 tt0 -91.82 -8.82 45.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.468 ' CG ' ' HA ' ' A' ' 459' ' ' LEU . 38.2 mm-40 -85.72 161.11 19.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.018 . . . . 0.0 109.359 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -124.14 162.94 18.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.888 HG23 ' CB ' ' A' ' 478' ' ' ALA . 84.1 mt -48.81 -38.27 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -1.095 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -69.29 -38.08 78.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.76 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.55 -46.7 88.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 459' ' ' LEU . 5.0 mp -85.1 -10.6 56.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.73 60.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.16 -27.0 63.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 109.59 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.608 ' CG2' HD23 ' A' ' 473' ' ' LEU . 43.2 mm -59.09 156.81 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 470' ' ' ILE . 84.2 tt0 -97.94 133.18 42.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.303 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.416 ' C ' HD22 ' A' ' 473' ' ' LEU . . . 91.54 9.76 62.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.706 HD13 ' HD3' ' A' ' 477' ' ' LYS . 3.8 mm? -108.55 140.95 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -1.093 . . . . 0.0 109.343 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -125.62 167.79 14.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.171 -0.956 . . . . 0.0 109.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 464' ' ' ILE . 90.1 m-20 -55.79 -36.93 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.706 ' HD3' HD13 ' A' ' 473' ' ' LEU . 59.4 tttt -60.99 -38.18 85.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.876 . . . . 0.0 109.142 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.888 ' CB ' HG23 ' A' ' 464' ' ' ILE . . . -57.74 -40.62 80.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 108.864 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 483' ' ' MET . . . -64.88 -73.65 0.56 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 479' ' ' GLY . . . -39.71 -37.08 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.364 -1.08 . . . . 0.0 109.738 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.784 HD11 ' O ' ' A' ' 439' ' ' GLY . 2.8 mm? -65.62 -66.19 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.152 -0.968 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 467' ' ' LEU . 82.9 mt -66.91 -32.0 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.847 . . . . 0.0 109.429 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 487' ' ' ASN . 97.6 mmm -62.05 -35.01 77.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.449 -0.782 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.51 79.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 109.306 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.779 ' HA ' HD21 ' A' ' 456' ' ' LEU . . . -75.75 -40.82 54.76 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.296 -0.877 . . . . 0.0 109.012 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 460' ' ' ALA . 91.4 mtt180 -68.76 -44.27 74.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 483' ' ' MET . 89.3 m-20 -59.8 -37.96 80.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 109.372 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . . . . . . . . . 81.2 mt -84.61 -40.81 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.853 . . . . 0.0 110.182 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.83 ' SG ' HD23 ' A' ' 456' ' ' LEU . 49.0 m -78.17 -39.04 42.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.993 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 48.8 m0 -93.89 -84.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.967 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 487' ' ' ASN . 14.8 m-85 -43.78 -41.97 5.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -80.2 132.13 11.08 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -96.46 6.61 48.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -1.147 . . . . 0.0 109.553 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.38 -33.2 74.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.536 ' HB1' ' OE2' ' A' ' 457' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.474 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -57.14 -34.22 68.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -1.168 . . . . 0.0 109.432 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.478 ' HB3' ' SG ' ' A' ' 454' ' ' CYS . 85.9 m-20 -93.34 143.66 26.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 0.7 OUTLIER -109.93 149.91 40.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.308 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.739 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 53.2 Cg_endo -73.2 146.03 40.02 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.576 2.184 . . . . 0.0 111.812 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 455' ' ' THR . . . -76.08 149.35 37.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.166 -0.959 . . . . 0.0 109.111 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 90.8 m-20 -51.97 -32.17 32.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -59.55 -42.1 91.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.998 -1.064 . . . . 0.0 108.991 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.848 ' CD2' HG11 ' A' ' 440' ' ' VAL . 0.5 OUTLIER -79.86 -51.21 9.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 445' ' ' ALA . 10.8 tp -48.42 -45.68 36.47 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.578 0.704 . . . . 0.0 109.129 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 65.0 m-80 -83.58 0.17 47.85 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 1.08 HD23 HG23 ' A' ' 440' ' ' VAL . 19.0 tp -67.08 127.34 32.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -60.59 -27.29 67.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.943 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.751 ' HA3' HD13 ' A' ' 481' ' ' LEU . . . -86.7 -4.26 82.86 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 1.08 HG23 HD23 ' A' ' 437' ' ' LEU . 59.8 t -124.23 116.66 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.373 -1.075 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.99 174.94 10.78 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.44 -44.66 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.054 -1.029 . . . . 0.0 108.696 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -67.72 -45.72 74.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.611 -0.681 . . . . 0.0 110.112 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.84 HD22 HG13 ' A' ' 440' ' ' VAL . 7.8 tt -58.42 -32.83 69.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.068 . . . . 0.0 109.405 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -61.18 -30.56 70.48 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 109.294 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -76.38 -53.88 7.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.233 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.828 ' HD3' HG23 ' A' ' 470' ' ' ILE . 18.3 tttp -56.77 -37.33 70.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.168 -0.957 . . . . 0.0 108.667 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 434' ' ' LEU . 10.0 tt -75.34 -43.28 51.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.905 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 430' ' ' PRO . . . -67.34 -34.54 77.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -72.47 -7.96 52.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 470' ' ' ILE . 22.0 ttt-85 -94.01 14.76 18.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.624 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.26 -15.58 57.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.598 ' HB ' ' CD2' ' A' ' 448' ' ' LEU . 0.9 OUTLIER -89.16 75.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.424 -1.044 . . . . 0.0 108.979 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 428' ' ' ASN . 2.8 m -81.79 -11.42 59.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.278 -179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . 0.534 ' HA ' ' CB ' ' A' ' 431' ' ' ALA . 2.3 p -124.81 151.28 45.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.888 -1.133 . . . . 0.0 110.046 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.803 ' HG ' ' HB1' ' A' ' 485' ' ' ALA . 5.2 tp -55.68 -38.36 69.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 108.891 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.55 -43.98 93.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 108.781 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.582 ' HB3' HG13 ' A' ' 453' ' ' VAL . 93.8 m-20 -53.55 -38.92 64.31 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 459' ' ' LEU . 2.0 tt -68.27 -43.26 78.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 109.284 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.524 ' HA ' ' HG3' ' A' ' 486' ' ' ARG . . . -54.14 -24.01 16.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 461' ' ' GLU . 82.6 tt0 -90.76 -9.14 47.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 458' ' ' ASP . 49.3 mm-40 -82.23 159.35 23.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.661 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -115.18 163.24 12.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 478' ' ' ALA . 88.2 mt -51.93 -37.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -70.99 -36.1 72.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.835 . . . . 0.0 109.846 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -66.48 -44.61 82.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 482' ' ' ILE . 40.4 mt -84.19 -14.14 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.27 -31.29 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.13 -29.8 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -0.841 . . . . 0.0 109.395 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.828 HG23 ' HD3' ' A' ' 447' ' ' LYS . 34.4 mm -58.09 155.58 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -104.73 144.22 32.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 90.85 -0.35 76.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 473' ' ' LEU . 12.8 mt -115.33 135.16 54.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -1.206 . . . . 0.0 109.424 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 177.04 4.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.59 -33.97 74.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -75.8 -42.57 49.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.155 -0.966 . . . . 0.0 109.451 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 477' ' ' LYS . 17.2 mtpp -66.84 -38.85 87.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.14 -0.975 . . . . 0.0 109.268 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -63.66 -42.86 98.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 483' ' ' MET . . . -67.18 -34.9 87.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.2 -58.99 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -1.075 . . . . 0.0 109.07 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.751 HD13 ' HA3' ' A' ' 439' ' ' GLY . 4.4 tp -46.49 -55.77 7.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.376 -0.828 . . . . 0.0 109.218 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.745 HG12 HD21 ' A' ' 459' ' ' LEU . 54.7 mt -57.96 -39.37 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.63 ' HE2' ' O ' ' A' ' 479' ' ' GLY . 19.3 mtm -70.65 -27.97 64.45 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.1 -40.96 91.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 0.0 108.686 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.803 ' HB1' ' HG ' ' A' ' 456' ' ' LEU . . . -75.17 -35.76 61.57 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.733 ' HD2' HG22 ' A' ' 482' ' ' ILE . 9.2 mtt180 -67.01 -43.72 82.17 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 492' ' ' GLY . 87.1 m-20 -62.85 -34.2 76.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.586 -0.696 . . . . 0.0 109.573 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 484' ' ' ALA . 77.2 mt -82.81 -41.68 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 0.0 109.984 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.5 m -77.64 -30.21 52.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.957 . . . . 0.0 109.697 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 486' ' ' ARG . 49.2 m0 -97.91 -83.43 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.552 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -53.1 -38.79 62.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.473 -0.767 . . . . 0.0 109.274 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -58.78 123.76 34.45 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 494' ' ' GLU . 28.3 p-10 -67.55 -33.16 74.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -1.126 . . . . 0.0 109.293 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 493' ' ' ASP . 97.5 mt-10 -62.84 -32.88 74.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.467 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.83 -25.72 68.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -1.189 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ASN . . . . . 0.826 ' O ' ' HB1' ' A' ' 449' ' ' ALA . 20.6 m120 -92.21 13.17 19.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 454' ' ' CYS . 4.7 mttm -64.67 150.64 93.82 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.69 ' CB ' ' HB1' ' A' ' 445' ' ' ALA . 50.0 Cg_endo -71.04 145.64 50.29 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.746 2.297 . . . . 0.0 112.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 454' ' ' CYS . . . -76.74 153.82 34.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.732 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.556 ' O ' ' ND2' ' A' ' 436' ' ' ASN . 12.6 p-10 -55.97 -30.56 61.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 437' ' ' LEU . 71.3 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.922 -1.111 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 448' ' ' LEU . 9.9 tp -76.79 -50.56 13.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 442' ' ' ARG . 5.2 mt -54.53 -43.72 72.18 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.614 -0.679 . . . . 0.0 109.938 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 432' ' ' ASP . 60.8 m-80 -84.78 0.64 49.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.877 . . . . 0.0 110.135 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 456' ' ' LEU . 16.6 tp -79.97 125.36 29.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.278 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.93 137.78 56.42 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.372 -0.83 . . . . 0.0 109.716 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.563 ' C ' HD11 ' A' ' 481' ' ' LEU . . . 99.74 -16.01 59.08 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.773 HG11 ' HG ' ' A' ' 434' ' ' LEU . 97.6 t -123.48 111.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -1.004 . . . . 0.0 109.327 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -89.22 171.47 9.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.767 ' HA ' HD23 ' A' ' 435' ' ' LEU . 43.1 ttt85 -56.15 -36.53 68.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.349 -0.844 . . . . 0.0 109.135 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.65 -54.09 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.435 -0.791 . . . . 0.0 109.631 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 444' ' ' LEU . 5.9 tt -59.52 -27.87 66.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.033 . . . . 0.0 108.814 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.69 ' HB1' ' CB ' ' A' ' 430' ' ' PRO . . . -64.53 -29.62 70.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 108.897 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.94 -46.73 42.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 108.851 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.674 ' HG2' HG23 ' A' ' 470' ' ' ILE . 44.9 tptt -63.38 -30.51 71.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 108.848 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.87 HD12 HD23 ' A' ' 434' ' ' LEU . 2.1 tm? -85.16 -42.02 15.12 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.52 -0.737 . . . . 0.0 109.167 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 428' ' ' ASN . . . -70.12 -31.63 69.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -70.02 -4.63 21.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.62 ' HD2' HD11 ' A' ' 470' ' ' ILE . 0.0 OUTLIER -101.4 16.49 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.86 . . . . 0.0 109.514 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.44 -18.6 44.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.668 HG13 ' C ' ' A' ' 458' ' ' ASP . 2.8 t -80.48 68.08 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -1.027 . . . . 0.0 108.855 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 429' ' ' LYS . 3.3 m -79.87 -8.37 59.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 110.337 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.5 p -126.33 151.69 47.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.753 -1.217 . . . . 0.0 109.907 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.796 HD11 ' CB ' ' A' ' 485' ' ' ALA . 6.4 tp -56.69 -37.78 71.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.441 -0.787 . . . . 0.0 108.933 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.53 ' CG ' ' SG ' ' A' ' 489' ' ' CYS . 91.0 mt-10 -59.67 -39.47 84.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ASP . . . . . 0.668 ' C ' HG13 ' A' ' 453' ' ' VAL . 94.6 m-20 -62.22 -33.93 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 467' ' ' LEU . 3.2 tm? -73.21 -34.69 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.376 -0.827 . . . . 0.0 109.081 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 486' ' ' ARG . . . -59.25 -26.65 65.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 108.896 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -83.71 -9.28 58.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.659 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLN . . . . . 0.575 ' CG ' HD22 ' A' ' 459' ' ' LEU . 50.7 mm-40 -79.5 160.4 26.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.031 . . . . 0.0 109.525 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.96 159.04 15.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.796 HG23 ' HB3' ' A' ' 478' ' ' ALA . 90.2 mt -53.67 -37.5 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -1.12 . . . . 0.0 109.729 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -67.41 -37.37 82.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.64 -46.22 69.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 482' ' ' ILE . 4.9 mp -72.63 -26.29 61.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 109.576 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ALA . . . . . . . . . . . . . . . -50.96 -32.01 19.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.575 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.14 -25.27 68.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.674 HG23 ' HG2' ' A' ' 447' ' ' LYS . 28.9 mm -65.16 163.46 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.578 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 470' ' ' ILE . 85.3 tt0 -103.72 139.62 38.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.71 81.11 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 467' ' ' LEU . 13.3 tp -106.13 135.02 48.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' THR . . . . . 0.448 ' OG1' ' HD3' ' A' ' 477' ' ' LYS . 0.0 OUTLIER -109.22 171.23 7.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.29 -44.32 96.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.399 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.83 -43.77 87.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.508 ' O ' HD23 ' A' ' 481' ' ' LEU . 20.5 mtpt -62.77 -45.84 90.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.796 ' HB3' HG23 ' A' ' 464' ' ' ILE . . . -59.69 -37.9 80.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.407 -0.808 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 483' ' ' MET . . . -63.78 -41.14 98.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 484' ' ' ALA . . . -80.87 -51.56 8.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -1.116 . . . . 0.0 109.588 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.585 HD12 HG23 ' A' ' 440' ' ' VAL . 4.4 mm? -50.69 -56.13 13.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.231 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 467' ' ' LEU . 71.9 mt -64.97 -36.48 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.795 . . . . 0.0 109.648 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 479' ' ' GLY . 34.1 mtp -72.94 -31.88 64.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 480' ' ' ALA . . . -66.77 -40.82 88.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.145 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ALA . . . . . 0.796 ' CB ' HD11 ' A' ' 456' ' ' LEU . . . -74.3 -41.21 61.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.462 -0.774 . . . . 0.0 109.085 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.768 ' HD2' HG22 ' A' ' 482' ' ' ILE . 13.8 mtp180 -65.08 -43.86 90.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.458 -0.777 . . . . 0.0 108.994 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 492' ' ' GLY . 89.9 m-20 -59.7 -39.68 85.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.385 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 484' ' ' ALA . 84.8 mt -77.38 -38.49 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 109.837 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' CYS . . . . . 0.698 ' SG ' HD23 ' A' ' 456' ' ' LEU . 1.9 m -79.86 -30.49 40.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.723 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' TRP . . . . . 0.422 ' CH2' ' CZ ' ' A' ' 486' ' ' ARG . 47.7 m0 -102.78 -83.93 0.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.316 -0.865 . . . . 0.0 109.612 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -46.25 -38.06 8.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 487' ' ' ASN . . . -46.12 -42.35 12.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -61.28 -34.27 74.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -1.144 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -76.21 141.2 41.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.565 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.469 179.938 . . . . . . . . 0 0 . 1 stop_ save_